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EXECUTIVE SUMMARY
Shortages of human resources for health services have hindered the rollout of antiretroviral treatment
(ART) across sub-Saharan Africa. Initial ART rollout models were physician- and hospital-intensive,
necessitating task-shifting to quickly expand the capacity of the health workforce to address the burden
of ART care services. The World Health Organization (WHO) defines task-shifting as a process of
delegation whereby tasks are moved where appropriate to less specialized health workers. Uganda is one of
the countries that has adopted task-shifting for ART care. A review of the policy environment for taskshifting was conducted in Uganda in 2009 and it showed high-level support in the Ministry of Health for
task-shifting, and a recommendation was made to develop national-level policies and guidelines on taskshifting. However, in developing such guidelines, it would be beneficial to define which tasks can be safely
shifted and to which cadre of staff as well as the pre-requisite training needed by these cadres to carry out
these tasks. Uganda has a good number of ART task-shifting programs, which should be documented and
disseminated widely to guide the policy development process. The purpose of our study, therefore, was to
examine examples of task-shifting programs in Uganda with the aim of generating data that could inform
the development of task-shifting policies, guidelines, and practices.

OBJECTIVES

The overall purpose of this study was to contribute to the growing knowledge base about task-shifting by
describing the service delivery approaches of three purposively selected major AIDS service organizations
(ASOs) in Uganda that have adopted task-shifting: Kitovu Mobile, Uganda Cares (UC), and The AIDS
Support Organization (TASO).
The specific study objectives were to:
1. Provide a description of task-shifting approaches in three Ugandan HIV treatment organizations.
2. Document the following patient-level outcomes: knowledge about ARVs, patient recall of interaction
with providers and level of satisfaction, and ART adherence and retention among patients accessing
services in these three organizations.
3. Document the following health system outcomes: quality of care, time spent by patients, and cost per
patient visit in these three organizations.

METHODOLOGY

Several approaches were used in responding to the three study objectives:
yy Objective 1 was addressed using existing program reports and qualitative interviews with key
informants and providers from these three organizations.
yy Objective 2 and part of Objective 3 (quality of care, time spent by patients) were addressed using
quantitative cross-sectional surveys (time-motion study, exit interviews, and client-provider interaction
observations) with patients accessing services at these three organizations, and a retrospective review of
patient registers.

Retrospective review of task-shifting community-based programs supporting ARV treatment and retention in Uganda ■ 1

•

Objective 3 (cost per visit) was addressed by a retrospective review of accounting data.

ART task-shifting can take place at a central health facility, e.g., when a nurse at a central clinic is
delegated authority to order or prescribe the refill of ARV supply for stable ART patients without
requiring a doctor’s prescription. On the other hand task-shifting can take place by shifting ART care
from the central health facility to decentralized clinics, e.g., community outreach settings. Task-shifting
also varies by the type of task being delegated, e.g., a highly clinical task like initiation of ART or a less
clinical task like patient triage. Thus to completely understand the type of task-shifting being referred to
we need to describe at least three dimensions: a) by place—a decentralized clinic can be considered to be
more task-shifted than a central one; b) by provider—delegation from a doctor to a lay health worker can
be considered to be more task-shifted than from a doctor to a clinical officer; and c) by task—delegation
of ART initiation can be considered to be more task-shifted than delegation of patient triage (Figure 1).
For the purposes of this report, we defined highly task-shifted clinics as clinics providing ART care at
relatively more decentralized sites, often using lower level health workers with more clinical tasks being
delegated, and minimally task-shifted clinics as those that provide ART care at relatively more central
health facilities using higher level health workers and minimizing the delegation of the more clinical tasks.
This definition allows different service delivery models to be located at varying points on a spectrum from
highly task-shifted to minimally task-shifted depending on the three factors: place, provider, and task.

KEY FINDINGS
Description of task-shifting approaches of the three ASOs
Kitovu Mobile: Kitovu Mobile delivers its ART services through task-shifting using non-facility-based
community locations and does not have a central clinic. Currently Kitovu Mobile has 111 community
outreach sites delivering ART care. The health workers travel by a project vehicle to meet groups of
patients at a community location such as a church, the verandah of a home, or under a tree. Thus all the
Kitovu Mobile clinics are in a highly task-shifted model.
Uganda Cares: UC operates two types of ART task-shifting models: 1) Uganda Cares stand-alone (UC-S)
clinics which are located at UC-owned centers and 2) Uganda Cares MOH (UC-MOH) which provides
drugs and other supplies to Ministry of Health (MOH) staff to provide HIV care at MOH health
facilities. Both UC models are considered minimally task-shifted.
The AIDS Support Organization: TASO delivers HIV care through its 11 service delivery centers.
Each TASO center has two types of task-shifting models: 1) central, minimally task-shifted clinics—
TASO-Central (TASO-C) and 2) about 30 highly task-shifted outreach clinics per TASO center—the
community-based drug distribution points (TASO-CDDPs). Patients are initiated on ART at the
TASO-C clinics and when they stabilize on ART they are referred to a TASO-CDDP of their choice,
where they receive ARV refills on an ongoing basis from a TASO counselor assisted by clients that
TASO has identified as “expert clients.” CDDPs are conducted on a specific day every other month in
a community location such as a place of worship or under a tree. On average there are 30 patients per
CDDP. ART patients attending TASO-CDDPs who require a clinical review are referred back to TASO-C
for that review, after which they return to the TASO-CDDP to resume ongoing ARV refill. Thus, no
TASO patients are categorically CDDP or central clinic patients, but rather each patient receives some
services at the CDDP and the central clinic.
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Shifting of tasks: The health worker (HW) interviews showed that more tasks tended to be delegated
from the health workers at the apex of the medical profession—doctors and clinical officers—than were
delegated to them. For the mid-level health workers—nurses and counselors—there was similar likelihood
of tasks being delegated from and to them. Tasks were more likely to be delegated to than from providers
at the bottom of the rank—expert clients and HIV medics. For example, the facility audits showed
that the task of nurses to perform pre-clinical care was delegated to lay health workers (LHWs) in all
the models while nurses were having the tasks of clinical assessment, counseling, and dispensing being
delegated to them in some models. Similarly, at TASO-CDDP, facility audits showed that counseling was
delegated from counselors to LHWs while counselors got the tasks of dispensing drugs delegated to them.
Training: The majority of professional health workers (PHWs) and LHWs who were delivering ART in
all models reported receiving training in ART care—in Kitovu Mobile, 82 percent (9/11) PHWs and
100 percent (26/26) of LHWs; in UC, 100 percent (50/50) of PHWs and 93 percent (39/42) of LHWs;
and in TASO, 83 percent (74/89) of PHWs and 84 percent (31/37) of LHWs. About half or more of
LHWs reported having been trained in ART counseling and health education, which perhaps reflects
the two tasks that were most delegated to them. For example, the following proportions of LHWs were
trained in counseling: in Kitovu Mobile, 88 percent (23/26); in UC, 71 percent (30/42) and in TASO, 49
percent (18/37). However, half or less of PHWs reported receiving training in the specific skills required
of them—prescribing and dispensing. For example, the following proportions of PHWs were trained in
prescribing: in Kitovu Mobile, 36 percent (4/11); in UC, 50 percent (25/50); and in TASO, 39 percent
(35/89).

Patient-level outcomes
Client exit interviews showed that client knowledge1 about ARVs was low (32–35 percent) in all three
ASOs. However, patient recall of receiving key elements of an ARV discussion with the provider in
the clinic that day varied from 59 percent to 66 percent and was significantly higher in the facilitybased clinics compared to community-based settings (p < 0.05). Client satisfaction with the services
received that day was over 90 percent in all models but was significantly higher in the facility-based
clinics compared to community-based settings (p < 0.05). This difference in recall, while significant, was
programmatically marginal at 7 percentage points, and it is important to note that client satisfaction was
quite high in both community-based and facility-based clinics.
Regarding ARV adherence while in ART care—as measured by patient medication refill records—patient
histories from the three ASOs after 24 months of follow-up showed 55 percent of patients had received
sufficient ARV medication to cover at least 95 percent of their expected treatment. Retention in ART
care was measured by compiling patient histories for patients who initiated ART between July 1 and
December 31, 2010 and determining what proportion was retained in care 24–30 months later, at
December 31, 2012. At 24 months, of the 2,223 patients from all sites, 1,667 patients (75 percent) were
actively retained in care, 16 patients (0.7 percent) had transferred to another facility, and six patients
(0.3 percent) had died. The remaining 24 percent of patients (534) had defaulted on their care without
resuming treatment by December 31, 2012, and had no final outcome documented in their records; all
Regarding ARV knowledge, the respondents were asked about the following aspects: benefits of ARVs, side effects of
ARVs, adherence requirements of ARVs, and what happens if one is not adhering to ARVs

1
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were deemed lost to follow-up. However, the quality and completeness of final patient outcome records
varied by organization and facility. Therefore, it was not possible to ascertain whether any patients who
were lost to follow-up may have actually died or transferred to another facility. From the perspective of
improving drug adherence, facilities should consider that any patients who default need support until the
patient resumes care or an ultimate outcome can be documented.
Only TASO provided data from ART services delivered to patients at a central facility and through a
community-based care model: the TASO-CDDPs. Bivariate analysis showed that stable TASO patients
who received any services through a CDDP were significantly more likely to be retained at 12 months
(OR: 16.3; 95% CI: 10.3–25.9) and 18 months (OR: 13.0; 95% CI: 8.5–20.0) than patients who
attended no CDDP-based visits. However these estimates may be influenced by patient treatment
preferences, or by patients who had received no CDDP-based services because they were not sufficiently
stable after their first three refill visits to attend.

Health systems outcomes
To examine the quality of care under task-shifted services, we observed the performance of key tasks
performed by various cadres of HWs during sessions of client-provider interaction (CPI). The results
show that provider performance in the clinical assessment2 of the patients did not differ by level of taskshifting—66 percent at community-based and 74 percent at facility based (p > .05) . There was also no
significant difference in adherence counseling—42 percent at community-based vs 55 percent at facilitybased (p > .05) and for counseling about side-effects—30 percent at community-based vs 42 percent at
facility-based (p > .05). However, there was a significant difference in addressing patients’ complaints: 70
percent at community-based vs 89 percent at facility-based (p < .01). Therefore, while the performance of
providers at community-based settings was similar to those at facility-based clinics in most tasks observed,
provider performance in addressing the patients’ complaints was significantly lower at the communitybased settings. At Uganda Cares, there was no difference in the performance of these tasks between HIV
medics (lay health workers) on one hand and professional health workers (doctors, clinical officers, and
nurses) on the other.
We also conducted time-motion studies to examine the time efficiency of these task-shifted services.
The median time spent at the clinic was 48 minutes at UC-S, 128 minutes at UC-MOH, 200 minutes
at TASO-CDDP, 221 minutes at TASO-C, and 225 minutes at Kitovu Mobile. Of this time, the time
spent waiting ranged from 33 minutes at UC-S to 195 minutes at Kitovu Mobile. The contact time with
clinic staff appears to be within the same order of magnitude across the five models (15 to 29 minutes).
However, the percentage of time spent in contact with the provider was highest at UC-S (37.5 percent)
and lowest at Kitovu Mobile (6.7 percent). Hence, there was poor time efficiency at the community-based
settings compared to facility-based clinics.

“Clinical assessment” includes the following basic clinical tasks: weighing the patient, asking about complaints, and
exploring issues mentioned by the client.

2
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Costing
Cost varied across sites within each organization as well as across the three organizations. In addition, the
number of annual ART visits was more frequent in rural areas and among Kitovu Mobile (community
distribution model), which played a major part in the overall annual ART cost. The annual cost per client
was $404 for Kitovu Mobile, $332 for TASO, and $257 for UC, which were lower than the previous
analyses in Uganda and the region (Menzies et al. 2011). ART drugs accounted for the majority of the
total cost, followed by personnel and operational costs.

CONCLUSIONS AND RECOMMENDATIONS

This study showed that in the three ASOs, almost all key tasks in ART, including determining eligibility,
initiating ART, and dispensing ARVs, can be feasibly shifted to lower level cadres or lower level facilities.
While WHO has defined task-shifting using one dimension—the personnel involved in the taskshifting—the data from our study adds two other dimensions that could be used for a more descriptive
definition—type of tasks delegated and type of facility to which ART services are delegated. The increased
analytic robustness of this approach leads us to believe that task-shifted services should be assessed across
all three dimensions: the type of cadre, the type of facility, and the type of task.
Our study has identified training gaps in specific areas of competence among PHWs and LHWs currently
providing ART in task-shifted services. Therefore, when rolling out task-shifting in Uganda, it will be
important to conduct training needs assessments of both the PHWs and LHWs and provide them with
the required training in order to ensure competence and quality of care in task-shifted services.
The data showed that some of the models demonstrated efficient use of patient time. The reasons for the
efficient use of patient time in models such as UC-S should be further explored and shared widely as best
practices that can strengthen other task-shifting models.
Our study provides the most recent available costing data from the three largest HIV service
organizations, representing three different ART service delivery models in Uganda. Unit costs, cost
distribution, and resource utilization varied widely across the three sites and models, suggesting the
potential for efficiency gains in ART service delivery. In particular, HIV programs in Uganda may save
costs by reducing the number of annual ART visits to the national standard (four ART visits a year on
average). Our findings of lower annual ART costs compared to previous analyses in Uganda and the
region indicate that we may be able to treat more people with the same or even fewer resources.
As referenced in the main body of the report, there is a growing body of literature on ART task-shifting.
Indeed, to date at least three meta-analyses have been carried out on the subject. In summary, the studies
point toward a general conclusion that task-shifting in any of the three dimensions—by type of provider,
by level of facility, and by complexity of task delegated—mostly seems to result in the same level of
outcomes when compared to the minimally task-shifted ideal of a doctor providing ART initiation and
maintenance in a hospital. However, some studies suggest better results from task-shifted ART care while
others suggest poorer results from task-shifted ART care. Our study has shown similar conclusions.
When we compared task-shifting by facility level we found that community-based settings were similar
to facility-based clinics with regard to the following indicators: ARV knowledge of clients; and provider
performance in clinical assessment of patients, adherence counseling, and counseling about side effects.
Our data also showed that community-based settings had better retention in ART. However, the data also
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suggest that community-based settings performed less well than facility-based settings on the following
indicators: client recall of discussions with provider, overall client satisfaction, provider performance in
addressing client’s complaints, and time efficiency. Thus our study has shown that in the three ASOs
almost all key tasks in ART including determining eligibility, initiating ART, and dispensing ARVs can be
feasibly shifted to lower level cadres or lower level facilities mostly with non-inferior outcomes compared
to non-task-shifted ART care. Findings from this study provide important insight on costs and outcomes
associated with task-shifting in facility-based versus outreach/community-based service environments
We thus make the following recommendations:
yy Consideration should be made to expand the description of task-shifted services along more than one
dimension: the type of cadre, the type of facility, and the type of task.
yy When rolling out task-shifting in Uganda it will be important to conduct a training needs assessment
of both the PHWs and LHWs and provide them with the required training in order to ensure
competence and quality of care in task-shifted services. Given the likelihood of staff attrition,
recruitment of new staff, and changes in guidelines, special attention should be paid to continued
medical education for all cadres of staff involved in ART care.
yy In our study we have shown that quality of care did not differ between HIV medics and other health
workers (doctors, clinical officer, and nurses) working at the same type of clinic (UC). This suggests
that the HIV medics are a cadre worth exploring for the scale-up of task-shifting.
yy The reasons for the efficient use of patient time in models such as UC-S should be further explored and
shared widely as promising practices that can strengthen other task-shifting models.
yy Kitovu Mobile should examine current ART dispensing (or documentation) practices as, on average,
the documentation shows that clients are receiving insufficient drugs to cover the interval between
refills, and only 19 percent of clients achieved 95 percent drug coverage during their time in care.
yy Given their low levels of drug coverage yet high levels of retention, Kitovu Mobile should consider
examining client viral loads to proactively identify any systemic concerns regarding viral suppression
and drug resistance.
yy Future programs might benefit from examining the distribution of costs among the different elements
of a task-shifted program, in order to identify care packages that deliver the highest quality of care at
the lowest cost.
yy The collection of costing data to measure unit costs, cost-effectiveness, and cost-efficiency remains
critical. ART service delivery sites in country would benefit from implementing a standardized cost
data-capture tool or M&E system that allows for comparison across sites.
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INTRODUCTION
PROBLEM STATEMENT

Uganda was one of the first countries to be heavily impacted by the HIV/AIDS epidemic since the
first AIDS case was identified in the early 1980s. The country is widely considered to be an HIV/AIDS
control success story having reduced its prevalence rate from 18.5 percent of adults aged 15–49 years in
1992 to 6.4 percent in 2004 (Uganda AIDS Commission 2014). However, it is estimated that 140,908
new infections occurred in 2013, and the HIV prevalence in the country rose to a national average of 7.3
percent (MOH 2011). The disease has created a severe and unsustainable burden on the already scarce
health-sector resources as funds are tapped from other sectors for HIV prevention and AIDS care and
treatment services. Approximately 1.1 million Ugandans have died from AIDS (MOH and ORC Macro
2006). Sexual transmission continues to contribute 76 percent of new HIV infections, while motherto-child transmission accounts for 22 percent of infections in the country (Uganda AIDS Commission
2011).
At the end of 2013 it was estimated that 1.6 million people were living with HIV in Uganda (Uganda
AIDS Commission 2014); and 69.4 percent of those eligible for antiretrovirals (ARVs), using the 2010
World Health Organization (WHO) guidelines, were on antiretroviral treatment (ART). However, using
the 2013 WHO guidelines, which have a lower cut-off threshold, those on ART would represent only
40 percent of those eligible for treatment (Uganda AIDS Commission 2014). The provision of ART has
enabled an entire generation of the country’s HIV infected population to live longer, more productive,
and healthier lives. However the advent of these lifesaving drugs comes with challenges to health care
systems of developing countries such as Uganda. Healthcare worker shortage is a major constraint to
ARV care in Uganda. While medical doctors are traditionally considered the most qualified health care
providers to determine patient eligibility for ART and initiate ART care, it is estimated that there is only
one doctor for every 22,000 patients in Uganda, which amounts to an 80 percent overall health worker
(HW) deficit (WHO 2007).

EMERGING SOLUTION:TASK-SHIFTING FOR PROVISION OF
ART

Shortages of human resources for health have hindered the rollout of ART across sub-Saharan Africa.
Current ART rollout models are physician and hospital intensive, highlighting that alternative, simplified
models are needed to quickly expand the capacity of the current health workforce. In 2008 WHO
developed guidance on task-shifting to address HW shortage and enhance access to ARV care in countries
such as Uganda. WHO defines task-shifting as a process of delegation whereby tasks are moved, where
appropriate, to less specialized HWs (WHO 2008).
To date at least three meta-analyses have been carried out on the subject of ART task-shifting. One
meta-analysis published in 2010 (Callaghan, Ford, and Schneider 2010) found articles covering three
dimensions: tasks—initiation and maintenance of ART; providers—delegation from doctors to nurses or
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to other non-physician providers; and level of facility—decentralized vs. central clinics. They reported that
among the studies they reviewed there was evidence of increased access to and retention in ART resulting
from task-shifting, the quality of care was equal or better with task-shifting, and task-shifting was costeffective. However, they observed that in one study task-shifted providers who had not received training
since their pre-service training were more likely to make errors, and in another study LHWs were worse
than PHWs at identifying clients eligible for ART. They highlighted the need for programs to identify
which tasks should and should not be delegated to some LHWs and the need for continued training of
providers.
Another meta-analysis published in 2013 (Kredo et al. 2013) reviewed task-shifting studies
comparing central vs. decentralized service sites. They grouped the studies into those examining
“partial decentralization,” where ART was initiated at a hospital and maintained at a health center;
“full decentralization,” where ART was initiated and maintained at a health center; and “ART in the
community,” where ART was initiated in a hospital or health center and maintained in the community.
The last category, “ART in the community,” is perhaps similar to the TASO model in our study. They
concluded that partial decentralization and full decentralization had reduced loss to follow-up compared
with hospital initiation and continuation. They also reported no difference in loss to follow-up, virological
and immunological outcomes, and death between any of the levels of decentralization.
A third meta-analysis published in 2014 (Kredo et al. 2014) focused on task-shifting studies comparing
type of provider and type of task delegated. In one group of studies comparison was made between
doctors and nurses or clinical officers (COs) for two tasks: initiating and maintaining ART. They reported
mixed results. The randomized controlled trials showed that there was no difference in mortality and
that there was less loss to follow-up with the nurses/COs compared with doctors. However, the cohort
data showed no difference in loss to follow-up but an increased risk of death in the nurses/COs arm. The
second group of studies compared doctors to nurses/COs for one task: maintenance of ART. Trials data
showed that there was no difference between arms in death and loss to follow-up. On the other hand,
cohort data showed that there were fewer deaths and fewer losses to follow-up in the nurses/COs arm
compared to doctors. The third group of studies compared doctors to LHWs for one task: maintenance of
ART, and for type of facility: doctors delivering ART in hospitals and LHWs delivering ART in homes.
There were no cohort studies in this group of studies but the trials data showed no difference in death and
loss to follow-up between the two arms.
In response to the growing evidence base, Uganda extended its human resource capacity for delivering
HIV/AIDS services by creating a range of non-professional HWs who are trained to provide specific
aspects of ARV care. Consequently, the burden of patient care began to shift to lower level HWs such as
nurses, pharmacists, expert clients, and community health workers (CHWs). Ugandan nurses assumed
a range of tasks that formerly fell within the purview of doctors including managing opportunistic
infections among people living with HIV (PLHIV), diagnosing tuberculosis based on sputum results,
deciding whether PLHIV have medical eligibility for ART, and managing side effects for people on ART
(WHO 2007). Consequently the delegation of responsibility goes further, as tasks that formerly fell under
the responsibility of nurses have been shifted to CHWs who have received job-related training, but do not
necessarily possess professional qualifications.
An increasing number of studies have highlighted the impact of ART task-shifting programs in Uganda.
One study examined ART task-shifting in 12 MOH health facilities from three regions in Uganda where
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the performance of nurses and clinical officers was compared to doctors in the task of deciding to initiate
clients on ART and found concurrence between these three groups of professional health workers (Vasan
et al. 2009). In addition, shifting ART care tasks from doctors by establishing nurses-only visits and
pharmacy refills visits was reported to improve client time efficiency at the infectious disease institute
in Mulago Hospital, Kampala (Castelnuovo et al. 2009). Delegating ART care responsibilities further
down to community levels has also been tested. In an evaluation of a community-based ART program in
western Uganda, it was reported that there were improvements in both clinical outcomes and quality of
life, demonstrating that positive outcomes can be achieved in community-based ART programs (Alibhai
2009).
Shifting ART tasks from doctors to less costly providers could save money for the ARV program. An
analysis of the cost-saving aspect of task-shifting in ART care in Uganda was carried out and it was
concluded that task-shifting results in substantial cost and physician personnel savings in ART follow-up
in Uganda and can contribute to mitigating the health worker crisis (Babigumira et al. 2009).
For a new innovative care approach such as task-shifting it is vital to have evidence-based continued
quality improvement as it is rolled out. Reach-Out Mbuya (ROM) is a community-based ART program
in Uganda that implements and continuously evaluates task-shifting in its service delivery. ROM operates
a nurse-led ART care approach which was evaluated for time efficiency in 2008 in comparison to doctorled care in Mulago Hospital. It was reported that the nurse-clinicians at ROM spent twice the time with
patients compared with the doctors at Mulago (Wanyenze et al. 2010). In a further refinement of the
client flow at ROM in 2008 and 2009, it was possible to document improved time efficiency (Alamo et
al. 2013). Another approach used by ROM is to delegate to LHWs the task of monitoring ART patients
for side effects through home visits. A review of this program revealed various challenges that need to
be addressed including work overload and the need to triage patients so as to prioritize visiting unstable
patients over patients who have stabilized on ART (Alwano et al. 2012). The experience of ROM shows
the need to continue refining task-shifting programs using rigorous evaluations to inform decision
makers.

TASK-SHIFTING STRATEGIES

Task-shifting can be examined in at least three dimensions: the tasks that are shifted, the providers
between whom the tasks are shifted, and shifting of service delivery venues from higher level, centrally
located, health facilities to lower level, decentralized sites. In the 2008 WHO guidelines (WHO 2008)
task-shifting is characterized using one dimension—the personnel. Our study seeks to expand the above
definition by characterizing task-shifting along two additional dimensions—type of tasks delegated, and
type of venue to which ART services are delegated. Figure 1 illustrates this three-dimensional nature of
task-shifting. In the top-left corner is the minimally task-shifted situation, for example a hospital where
doctors initiate patients on ART and keep seeing them routinely for clinical monitoring and ARV refill.
It is shown that the amount of task-shifting can be increased in three planes: a) decreasing provider
qualifications from doctor to clinical officer to nurse and lay health worker (LHW); b) decreasing facility
level from hospital to health center and community setting; and c) increasing complexity of task delegated
from patient triage to ARV refill to initiation of ART. Maximizing task-shifting in all three dimensions
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Figure 1:Three-dimensional framework of task-shifting
Decreasing provider
qualifications
Minimally
task-shifted

Increasing complexity of
tasks delegated

Decreasing facility
level
Highly
task-shifted

can result in a highly task-shifted situation where, for example, trained LHWs are initiating clients on
ART in a community setting.

Tasks that can be shifted
Task-shifting strategies are relative to which tasks are delegated and are also often context specific.
Callaghan and colleagues (Callaghan, Ford, and Schneider 2010) report that the tasks performed by the
lower cadres include triage at the clinic, adherence support, review of signs and symptoms of drug toxicity
or disease progression, ART medication refill, and HIV testing and counseling of family members.
Examples of ART tasks that can be shifted in various task-shifting models include:
yy ART initiation: Review of the patient’s history, conducting psychosocial assessments, conducting a
physical exam, interpreting relevant laboratory test results to make a decision about whether the patient
is eligible for ARVs, and writing the first prescription of ARVs for the patient.
yy ARV refill: Review of the ART patient’s adherence and any side effects, conducting a physical exam,
and interpreting any laboratory test results to make a decision to prescribe or order a re-supply of ARVs
for the patient.
yy Dispensing of ARVs: Interpretation of a prescription or order of ARVs for a patient, counting or
obtaining the correct quantity and types of the prescribed or ordered ARV drugs, handing the ARVs
to the patient as well as explaining the usage of the drugs to the patient and ensuring understanding of
instructions.

Task-shifting among providers
Task-shifting involves the delegation of tasks from a higher level standard provider to a lower level
member of the ART team. Typically the ART team comprises several categories of personnel including
(WHO 2008; Zachariaha et al. 2009):
yy Clinicians (doctors and clinical officers) whose standard roles are to carry out patient consultation,
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manage opportunistic infections, clinical staging, and ART initiation.
yy Nursing staff (nurses and nursing assistants) whose standard roles are triage, supervising CHWs, and
supporting doctors by preparing individuals for ART and monitoring ART recipients.
yy Counseling staff (counselors and counseling assistants) whose standard role is to provide adherence
counseling.
yy Pharmacy staff whose standard role is dispensing medicines.
yy Lay providers (expert clients, CHWs, village health teams, etc.) who are usually trained by
organizations to carry out specific aspects of care and support including triage, health talks, adherence
counseling, and emotional support.
yy Other providers including laboratory staff, family members, etc.

Task-shifting between health care facilities
ART task-shifting can take place at a central health facility, e.g., a national or district hospital which
normally provides HIV treatment. One example is when a nurse at such a central clinic is delegated
authority to order or prescribe the refill of ARV supply for stable ART patients without requiring a
doctor’s prescription. On the other hand task-shifting can take place by shifting ARV care from the
central hospital to decentralized clinics, thus enhancing ART access for patients in areas distant from
central clinics (Callaghan, Ford, and Schneider 2010). The decentralized site could be a peripheral health
center, a community center, a place of prayer, a patient’s home, or just under a tree. In addition to shifting
the venue, the decentralized clinics also often shift the personnel conducting some of the tasks, for
example, delegation of ARV refills prescription from a doctor to a nurse. In this sense the decentralized
clinics can be considered to be highly task-shifted compared to central clinics since the decentralized
clinics have shifted the venue and the personnel while the central clinics may only shift the personnel
(minimally task-shifted).

Need for further exploration of task-shifting in ART care
Task-shifting in the context of ARV care has been taking place in Uganda and other sub-Saharan African
countries as a strategy to enhance access to ARV care. While WHO has developed global guidance
(WHO 2007) on task-shifting, there is need for countries such as Uganda to develop national policies
and guidelines to guide the roll-out of task-shifting and best practices. To this effect, a review of the policy
environment for task-shifting was conducted in Uganda in 2009 that found a high level support for
task-shifting and made recommendations to develop national level policies and guidelines on task-shifting
(Dambisya 2012). However, in developing such guidelines it would be beneficial to define which tasks
can be safely shifted and to which cadre of staff (Callaghan, Ford, and Schneider 2010), as well as the prerequisite training needed (Lutalo et al. 2009) by these cadres to carry out these tasks. While the literature
about ART task-shifting in Uganda is growing, Uganda still has a good number of ART task-shifting
programs that have not been adequately documented or disseminated (East, Central, and Southern
African Health Community 2010). The purpose of our study, therefore, was to examine examples of
task-shifting programs in Uganda with the aim of generating data that could inform the development of
task-shifting policies, guidelines, and practices.
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STUDY OBJECTIVES
The overall purpose of this study was to add to the growing body of knowledge about task-shifting
for ART and contribute to the strengthening of national policy and development of service delivery
guidelines that would indicate how task-shifting should be carried out, and the expected benefits of taskshifting to the patient and the health system.
The specific study objectives were to:
1. Provide a description of task-shifting approaches in three Ugandan HIV treatment organizations.
2. Document the following patient-level outcomes: knowledge about ARVs, patient recall of interaction
with providers and level of satisfaction, and ART adherence and retention among patients accessing
services in these three organizations.
3. Document the following health system outcomes: quality of care, time spent by patients, and cost per
patient visit in these three organizations.
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METHODOLOGY
STUDY DESIGN

Several approaches were used in responding to the three study objectives, including quantitative cross
sectional surveys, qualitative interviews, observation of service delivery, and a retrospective review of
service statistics and accounting data. The three AIDS service organizations (ASOs) included in the study,
started delivering ART in the 2002 (Uganda Cares), 2003 (TASO), and 2006 (Kitovu Mobile). They each
sooner or later applied task-shifting strategies in 2004 (Uganda Cares), 2004 (TASO), and 2006 (Kitovu
Mobile). The retrospective review of service statistics covered the period July 2010 to December 2012, the
retrospective review of accounts data covered the period January to December 2012, and the surveys were
conducted between June and September 2013.
Specifically:
yy Objective 1 (task-shifting approaches) was answered using existing program reports and qualitative
interviews with key informants and providers in participating organizations.
yy Objective 2 and part of Objective 3 (quality of care, time spent by patients) were answered using
quantitative cross sectional surveys (time-motion study, exit interviews) with patients accessing services
at the three organizations and a retrospective review of service statistics.
yy Objective 3 (cost per visit) was answered through a retrospective review of accounting data.
Table 1 summarizes the different data collection methods corresponding to the three study objectives.
Table 1 Study methodology overview
Output

Data collection

Analysis

Description of task-shifting
approaches

Interviews with HWs

Descriptive statistics

Facility audits

Descriptive statistics

Review of program reports

Extraction of main themes about taskshifting

Client exit interviews

Descriptive statistics

Retrospective review of
service statistics

Adherence: Proportion of days covered
by drugs picked up

Document patient outcomes

Retention: Proportion of cohort still in
program at end date
Document health systems outcomes

CPI observations

Descriptive statistics

Time-motion study

Descriptive statistics

Retrospective review of accounting
data

Descriptive statistics
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STUDY SITES

We purposively selected three major organizations that provide HIV and ART services to PLHIV in
Uganda using a task-shifting approach: Kitovu Mobile, Uganda Cares (UC), and The AIDS Support
Organization (TASO). The three organizations were selected based on stakeholder recommendations
and the current task-shifting situation in Uganda. These three AIDS-service organizations (ASOs)
differ in size and service delivery approaches. Within each of these three ASOs, the selection of study
clinics was purposive, aimed to ensure a fair distribution across: 1) the geographical area of operation;
2) high- vs. low-patient volume clinics, and 3) highly task-shifted versus minimally task-shifted clinics.
For the purposes of this report we defined highly task-shifted clinics as clinics providing ART care at
community outreach sites and minimally task-shifted clinics as those that provide ART care at health
facilities. Overall, 28 facilities were selected across the three organizations. The distribution of the clinics
is summarized in Table 2, and details are provided in Figure 2.
Table 2 Summary of clinic selection
Patients
currently
on ART in
June 2014

Geographical
area of
operation

Geographical
area selected
for the study

Highly
task-shifted
clinics (High
volume)

Highly
task-shifted
clinics (Low
volume)

Minimally
task-shifted
clinics

Kitovu
Mobile

1,439

6 districts in
1 region

1 region

2

2

0

Uganda
Cares

50,039

13 districts in
4 regions

4 regions

0

0

9

TASO

68,584

11 centers in
10 regions

5 regions

5

5

5

Kitovu Mobile
Kitovu Mobile AIDS Organization commonly known as Kitovu Mobile is a faith-based organization
under the Catholic Diocese of Masaka, Uganda. The organization is among the pioneer programs for
home-based care in Uganda. It has provided HIV care and support since 1987 using a community
outreach model, thus its name—Kitovu Mobile. Kitovu Mobile has no central ART clinic. In this
study we categorized Kitovu Mobile as being a highly task-shifted model since ART service delivery was
decentralized to community outreach settings. Kitovu Mobile conducts its operations at 111 community
outreach sites located in six districts in the Central-1 region of Uganda. Within these six districts of
Kitovu Mobile operations, two districts were selected and within each district two clinics were selected:
one low volume and one high volume, resulting in a total of four clinics. The following clinics were
purposively selected by the study team based on information provided by the ASO to ensure a reasonable,
fair distribution across districts and low and high-volume clinics: Bukulura, Kabuwoko, Kyazanga, and
Mbirizi.

Uganda Cares (UC)
Uganda Cares (UC) started providing ART care at its first center in Masaka, Uganda in February 2002
(Uganda Cares 2003) and applied its HIV medic task-shifting program in 2004 (Hiner and Musokwa
2007). UC provides ART using two models. In one model the clinics are entirely owned and managed
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Figure 2 Map of Uganda showing
HIV prevalence in 2011 by region
and location of TASO, Kitovu
Mobile, and UC
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by the ASO—Uganda Cares Stand-alone (UC-S) clinics. In the second model UC provides drugs and
supervision to existing MOH clinics that provide ART using MOH personnel and premises—Uganda
Cares MOH (UC-MOH) clinics. There are no referral links between these two UC models. We consider
both UC models to be minimally task-shifted in that the ART services are provided at health facility
clinics as opposed to community outreach programs. Currently, UC is operating 29 clinics in 13 districts
in the North-East, Mid-East, Central-1, and Central-2 regions of the country. Among the four regions of
operation the study team purposively selected the following clinics with the aim of ensuring a reasonably
fair distribution across regions of Uganda and UC-S vs. UC-MOH: three UC-S clinics: 1) Soroti (NorthEast region), 2) Nakawa, and; 3) Balikuddembe (Central-2 region); six UC-MOH clinics: 1) Maddu, 2)
Rakai, 3) Lyantonde, and 4) Kalisizo (all four in Central-2 region); and 5) Mulanda and 6) Nagongera
(both in Mid-East region).

The AIDS Support Organization (TASO)
TASO is a large ASO that provides ART using clinics that are entirely managed by the ASO. TASO
started delivering ART care in May 2003 at its Tororo Center; in early 2004 TASO rolled out ART care
at all its centers. In mid-2004 TASO started its first task-shifting strategy when it trained and used lay
health workers to deliver ARV refills to client’s homes (Stilwell 2007). Currently, ART is provided at
TASO Central (TASO-C) clinics or at TASO Community Drug Distribution Points (TASO-CDDP)
clinics. The two TASO models have a two-way referral link in that patients who are stable on ART are
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referred from TASO-C to TASO-CDDP for ongoing ARV refills and CDDP patients who are unstable
or need a medical review are referred back to TASO-C. In this study we categorized the TASO-CDDP
model as being highly task-shifted because the services are delivered at community outreach settings and
the TASO-C model to be minimally task-shifted because the ART services are delivered at health facility
clinics.
The operational service delivery unit in TASO is called a center. TASO has 11 centers that are distributed
across the 10 regions of the country. Each TASO center serves three to five districts. For this reason,
the selection unit for TASO was a center rather than a district. Out of the 11 TASO centers, five were
purposively selected to ensure fair regional representation: Entebbe (Central 1 region), Jinja (East-central),
Gulu (Mid-north), Masindi (Mid-west), and Rukungiri (South-west). The central, minimally taskshifted clinic of each of these centers was included as a study site. In addition, for each TASO Center two
community drug distribution points (CDDPs), the highly-task-shifted clinics, were purposively selected
to ensure fairness in geographical and low- vs high- volume distribution. One high volume and one low
volume CDDP site was chosen from each center, resulting in the following 10 CDDPs: Bayita, BuhimbaKaruma, Buyanja, Dwoli-Biiso, Kanyinya, Kanyogoga, Kiyindi, Layibi, Masajja-Kawoto, and Red Cross.

DATA COLLECTION METHODS AND ANALYSIS
Facility audits
Facility audits were conducted in all 28 participating clinics by senior nurses who had received a fiveday training on data collection for this study. They visited the selected health facilities and observed the
delivery of ART for one full day, from the time the first patient was served up to when the last patient
was served. The facility audits were conducted at four Kitovu Mobile outreach clinics, six UC-MOH
clinics, three UC-S clinics, 10 TASO-CDDP clinics, and five TASO-C clinics. The observers completed
a quantitative facility audit tool and the data were entered in Epi Data and analyzed in Microsoft Excel
to generate simple frequencies for the following key study outcomes: opening and closing hours, number
and types of HWs present that day at the clinic, number of patients seen at the clinic, and the ART
tasks performed by each cadre of HWs. The facility audits also provided information about delegation of
tasks by documenting the cadres of health workers performing various tasks in ART care on the day of
the audit. In the analysis, the cadres documented by the facility audits as performing certain ART tasks
were compared to the cadres that, according to the World Health Organization (WHO 2008), were
conventionally supposed to perform those tasks.

Client-provider interaction (CPI) observations
At each clinic, at least 50 CPIs were observed, except at UC-S where only 45 sessions were available for
observation. Fifty patients at each clinic was deemed to be a feasible number that could be observed in
one or two days. This sample size is sufficient for this descriptive study.
Prior to observing a service delivery session the nurse-observers sought consent from the HW to observe a
session that the HW was about to conduct with a patient. After obtaining the HW’s signed consent, the
observer was introduced to the patient by the HW and the observer sought the patient’s signed consent to
observe the session. The observers were trained to remain silent and unobtrusive during the session. They
used a checklist of key ART care tasks which they checked using a three point scale of “Yes,” “Somewhat,”
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and “Not at all” to indicate whether, and how well, each task was performed by the HW during the
session.
The performances of HWs of the following key ART tasks were observed:
yy Assessment of the patient (weighing, asking about complaints, exploring issues);
yy Adherence counseling (asking about: missed dose, challenges in adherence, and family support;
discussing adherence on ARVs received that day);
yy Side effects counseling (asking about side effects; discussing signs and symptoms of side effects and what
should be done in case of side effects); and
yy Addressing complaints (providing solutions or referrals for each complaint raised by a patient).
These data were analyzed by creating an index of performance for each task observed. Each task for which
the observer’s response was “Yes” was scored two while the “Somewhat” response was scored one and
the “Not at all” response was scored zero. A sum of these values was then obtained for each task, which
became the numerator for calculating the percentage performance score for that task. The denominator
was obtained by multiplying the number of sessions observed by a factor of two which represents the
highest possible performance score (“Yes”).

Time-motion study
At each of the 28 selected clinics, a sample size of 50 patients was conveniently recruited for the timemotion component. Patients were followed by research assistants (RA) with a social science background
who had received a five-day training on data collection for this study. Each patient arriving at the health
facility was approached by a RA who sought their consent to be followed by the RA at all the stations of
the clinic as they received services. Using a time-motion study tool the RA recorded the time the patient
started receiving the service at each station, the cadre of the provider who served the patient at that
station, and the time the patient left that station. Simple statistics were generated describing patient’s time
spent at each station, time spent waiting between stations, and overall time spent at the health facility.

Client exit interviews
For the exit interviews component of the study, a sample size of 78 was calculated as sufficient for
detecting a difference of 15 percent in client satisfaction between two types of task-shifting models (95
percent CI and 80 percent power). A sample size of 80 patients was therefore selected in each clinic. The
interviews were conducted by RAs with a social science background who had received a five-day training
on data collection for this study. Descriptive data analysis was used to determine patient knowledge about
ARVs, patient recall of ART care services received during the clinic visit, and satisfaction with services
received.
Regarding ARV knowledge, the respondents were asked about the following aspects: benefits of ARVs,
side effects of ARVs, adherence requirements of ARVs, and what happens if one is not adhering to ARVs.
The proportion of patients who correctly answered each of these questions was calculated separately, after
which a simple average of these percentages was computed to represent the ARV knowledge level of the
respondents.
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On recall of services received, the respondents were asked if they recalled receiving the following discussion
or service from the provider3 in the clinic that day: talked with a HW about ARVs, remaining pills
counted, asked by HW about missing an ARV dose, and asked by HW whether taking other medicines.
The proportion recalling each of these services was calculated separately for each service, after which a
simple average was computed to represent recall of services received.
With regard to client satisfaction, the exit interview asked the following questions: whether the patient felt
that the HW listened to them and gave them a chance to ask questions, whether the patient was satisfied
with the time spent at clinic, whether they felt they had enough privacy during the consultation, whether
the discussion was helpful, and whether they would come back to that clinic to seek services in the
future. The proportion answering positively on each of these questions was calculated separately for each
question, after which a simple average was computed to represent satisfaction.

Interviews with health workers
HWs working in the study facilities were interviewed by RAs with a social science background who had
received a five-day training for data collection. The RAs interviewed as many of the HWs present at the
clinic on the day the study team visited the clinic as possible; in some cases they could not interview
HWs who were too occupied with care activities. The health worker interviews were administered to a
total of 268 HWs found working at these clinics on the day of the study, 150 (56 percent) of whom were
professional health workers while the rest were lay health workers. The breakdown per task-shifting model
is 40 HWs from Kitovu Mobile; 60 from UC-MOH, 28 from UC-S, 72 from TASO-CDDP, and 68
from TASO-C. The data were entered into Epi data and were analyzed in Excel for simple frequencies on
the following key outcomes: ART care tasks delegated out from the health worker and tasks delegated to
the health worker, as well as ART training received.

Review of program reports
The latest available annual reports for each ASO were reviewed to extract information about the history of
the organization, the number of districts and health facilities served by the ASO, and the number of HIV
patients enrolled in pre-ART and ART care. Information about the task-shifting approach of the ASO
was also obtained.

Review of service statistics
Data from clinical records of all patients aged 16 years and older who attended ART services in all clinics
run by the three organizations between July 2010 and December 2012 were collected. The following
information was obtained:
yy Date of initiation of ART
yy Personal information: age, sex, clinic ID number
yy Dates of return visits
yy Types and quantity of all ARV medications delivered to the patient

Health workers were not informed that their patients would be asked whether they received these discussions or
services

3
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To collect these data, trained data extractors visited the central offices of TASO, UC, and Kitovu Mobile
to review patient visit records from the organization’s electronic database. The data collectors constructed
patient histories by linking individual visit records over time, using unique patient identification numbers.
Only patient records that included the following were included in the analysis.
1. A valid date and visit location.
2. Whether the patient was to receive additional ART medication.
3. The types of ART dispensed, or documentation of the patient’s assigned ART regimen.
4. The number of pills of each drug dispensed.
The completed service statistics data were imported to the STATA 11 statistical package for final cleaning
and analysis. Using the available data, a number of variables were constructed to assess retention in care:
1. Inter-visit period: The number of days between two successive ART refill visits.
2. Drug adherence: The number of days the medication dispensed to a patient at each refill visit was
expected to last. For example, if a patient was prescribed an ARV drug regimen where one pill is taken
twice daily, and dispensing records indicate that 60 tablets were dispensed to the patient on his/her last
refill visit, then that patient had 30 days of drug coverage before the next refill visit. Patients who do
not attend a refill visit before their dispensed drugs are exhausted are considered non-adherent for the
additional days.
3. Default: Patients who had exhausted and remained non-adherent for more than 45 consecutive days
before receiving a documented refill were considered to be in default on planned treatment. The buffer
period of 45 days was selected for consistency with other ART programs.
4. Resuming care: Any patient who, after defaulting had returned for clinical services before December
2012.
5. Treatment gaps: the number of times that a patient defaulted and subsequently resumed care between
July 1, 2010 and December 31, 2012.
6. Loss to follow-up: Any patient was considered lost to follow-up if s/he defaulted on clinical services,
failed to resume care prior to December 31, 2012, and had no ultimate outcome recorded in the
clinical registry. The buffer period of 45 days was selected for consistency with other ART programs.
For this study, any patient who had entered default on or before November 18, 2012, did not complete
another documented visit by December 31, 2012, and had no documented reason for failing to attend
a refill visit was deemed lost to follow-up.
7. Total time in care: The number of days elapsed between a patient’s ART initiation date and their last
documented visit prior to December 31, 2012.
We assessed the two key patient-level outcomes based on the above variables:
1. Retention in care: Patients were considered retained in care if they were not lost to follow-up as of
December 31, 2012.

Retrospective review of task-shifting community-based programs supporting ARV treatment and retention in Uganda ■ 19

2. > 95 percent drug adherence: The proportion of patients, for whom at least 95 percent of their total
time in care was adequately covered by the ARV medication dispensed at their documented refill visits.
This indicator was used as a surrogate measure for adherence.
For TASO facilities only, association between the two outcomes and two task-shifted models (TASO-C
and TASO-CDDP) were also assessed using descriptive and bivariate data analysis. These associations
were not examined for Kitovu Mobile and UC sites due to data limitations, as discussed in the study
limitations section.

Collection of costing data
Costing analysis was undertaken from the provider’s perspective. Analysis only included costs that were
directly incurred by the provider, and excluded costs covered by clients. Ancillary and opportunity costs
incurred by patients such as transportation and time were not collected.
The ART drug costs, number of clients, number of visits, operational costs, and other costs related to
service delivery were collected retrospectively using routine monitoring and evaluation (M&E) data from
the three participating organizations, including accounting records, client visit logs, ART distribution
logs, equipment inventories, and routine reports. Salaries of staff providing ART services were collected
based on payroll records, including both salary and benefits. Time spent on ART service delivery
was determined based on interviews with staff and their managers. The time spent on ART was then
calculated as a ratio of the total number of hours spent on ART divided by the total working hours per
day (eight hours per day). The percentage of office rent and operational costs attributed to ART was
calculated based on the percentage of the ART program budget in relation to the total budget for the
organization.
Four TASO centers out of 11 total, and eight out of 29 UC clinics were randomly selected for the cost
study. Because Kitovu Mobile is much smaller in size and operates in only one region, all 111 Kitovu
Mobile outreach mobile units were selected. Data were collected for one calendar year. We chose to collect
the 2012 data to get the most recent data that would also be considered relevant and useful. Monthly
2012 data from sampled facilities were collected then aggregated for the whole year.
Apportionment of shared costs: Apportioning costs for staff not full time on ART service delivery was
estimated based on percentage of time spent on ART service delivery. For TASO, which has a regional
structure, personnel costs at the national level were equally shared among the four TASO centers in the
four regions. At Uganda Cares and Kitovu Mobile, headquarter operational costs attributed to ART were
equally distributed among all the service delivery points of the organization.
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RESULTS
HIV TREATMENT TASK-SHIFTING APPROACHES OF
PARTICIPANT ORGANIZATIONS

This section presents the description of the task-shifting approaches of the three ASOs studied, including
what tasks are delegated, which cadre is involved in task-shifting, at what locations task-shifting is taking
place, and how the task-shifting approaches were developed.

Kitovu Mobile
Kitovu Mobile has been providing ART care since 2006 through 111 outreach units in the hard-to=reach
communities. Since Kitovu Mobile does not have a central clinic, its HIV care services are entirely
delivered at community locations such as a church, the verandah of a home, or under a tree. According to
their service statistics, by June 2014 Kitovu Mobile had 1,833 current patients, of which 1,439 were on
ART; and had enrolled 110 new ART patients from January–June 2014.
How the ART task-shifting approach was developed
A review of program reports showed that the following measures were undertaken to integrate ART care
into the community outreach model of Kitovu Mobile:
a. Training of expert patients in ART care: The term “expert patients” refers to ART patients who have
received ART care for some time and have exhibited a high degree of understanding of ARV side
effects and adherence issues. They are then selected and given a short training in ART adherence
counseling and community education about ART, and become employed by Kitovu Mobile to
educate and counsel other patients about ART. At the time of our study Kitovu Mobile had trained
177 expert patients who functioned as treatment supporters for fellow patients and assisted nurses in
the conduct of the clinic.
b. Establishment of community outreach clinic locations: Kitovu Mobile was established as a home-based
care program that provided HIV care and other palliative care services to PLHIV by visiting each
patient at home. When the number of patients increased, a decision was made to ask the patients to
gather in one community outreach site where a visiting Kitovu Mobile team would meet them on the
appointed day. This is the model that is being used currently to provide pre-ART and ART care.
c. Process of the community outreach settings: At each site the clinic takes place once a month and the
day of the clinic is well known to the community via word of mouth and messages from village
health team (VHT) members. In addition, at each clinic day existing patients get an appointment
for their next clinic visit. Determining patient eligibility for ARVs, including collecting blood for
CD4 counts, is done by nurses who then develop a list of patients needing initiation on ARVs and
make appointments for the ART initiation team to meet the patients at their respective community
outreach site. The ART initiation team is led by a clinical officer. Once patients are initiated on
ARVs and have been well stabilized, they receive follow up from a nurse-led team at the community
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outreach site once a month to get their ARV refills and receive other HIV care. The nurse-led team
includes expert patients who provide education to waiting patients about the procedures of ART
initiation as well as the importance of adherence.
d. Supervision: When the clinical officer visits the community outreach settings to initiate new patients
on ART s/he also provides supervision to the nurses and expert patients and is able to examine
and treat any of the ART refill patients who the nurse identifies with additional clinical problems
requiring further care.
The data in Table 3 are from 37 HW interviews from Kitovu Mobile comprising 11 PHWs (1 clinical
officer, 4 nurses, 4 counselors, and 2 lab workers) and 26 LHWs (2 community health workers and 24
expert clients). It shows that in Kitovu Mobile the majority (9 out of 11) of PHWs and all 26 LHWs had
undergone a specific training on ART care. Regarding specific skills, however, a low proportion of PHWs
reported training in any of the four key skills: prescribing (4/11), dispensing (3/11), counseling (5/11),
and health talk (2/11). In contrast, the majority of LHWs reported having been trained in the two skills
of counseling, 88 percent (23/26), and health talk, 73 percent (19/26)—the two roles most delegated to
LHWs. It would have been interesting to examine proportions trained by each specific cadre (e.g., nurses)
but the sample sizes of each cadre were too small for comparison.
Table 3 Kitovu Mobile providers reporting ART-care training
Professional HWs (clinical officers, nurses, counselors, lab workers)

n = 11

Has received specific ART-care training

9

Topic of ART-care training:

Prescribing

4

Dispensing

3

Counseling

5

Health talk

2

LHWs (Expert clients,VHT)

n = 26
n (Prop)

Has received specific ART-care training
Topic of ART-care training

26 (1.0)

Prescribing

6 (0.2)

Dispensing

9 (0.3)

Counseling

23 (0.9)

Health talk

19 (0.7)

Data source: HW interviews; more than one response possible.

The data from the facility audit tool showed that among the four Kitovu Mobile clinics in the study the
average number of patients on the day of observation was 50 per clinic; it was observed that there were an
average of 3.25 nurses per clinic and 3.5 expert clients per clinic serving that day. Thus, the workload per
nurse was similar to the work load per expert client—14 to 15 patients per provider.
Table 4 shows how clinical tasks were delegated at Kitovu Mobile. It is shown that clinical review,
counseling, and dispensing that are conventionally supposed to be performed by clinical officers,
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counselors, and pharmacy workers, respectively, were documented as being performed by nurses, and preclinical tasks were performed by LHWs, implying that at Kitovu Mobile, which only has a highly taskshifted model, both the pre-clinical and clinical ART care tasks were delegated.
Table 4 Tasks delegated at Kitovu Mobile

Clinical review

N/A

Counseling

N/A

Dispensing

N/A

Counselor

Pharmacy
worker



LHW

N/A

Nurse

Pre-clinical (registration, triage, health talk, and vital signs)

Clinical
officer

Doctor

Performer of task















 - Conventional performer of task;  - Observed performer of task
Data sources: facility audits (n = 4)

Uganda Cares (UC)
UC is operated by the AIDS Healthcare Foundation (AHF)4 in partnership with the Ministry of Health
(MOH) and has provided HIV care in Uganda since 2002. According to their service statistics, UC had
50,039 current HIV patients; including 16,000 new patients in 2013.
How the ART task-shifting approach was developed
A review of program reports showed that UC, which was initiated in the ART era, undertook the
following measures to address the overwhelming workload of ART care on the few professional HWs
available:
a. Training of HIV medics: UC has a task-shifting approach that uses a cadre of trained lay health
workers known as “HIV medics” to assist in the provision of ART care. The HIV medic model of
UC started in 2004. It entails recruitment of lay people with a basic education of at least four years
of secondary school who are then given a 12 week didactic and practical training course in basic HIV
care, triage, and intensive adherence support in the provision of ART and ART monitoring.
b. Training of expert clients: In addition to HIV medics UC trains expert clients, who are selected from
among their HIV patients, to support the care of other patients.
c. Clinic process: During the ART clinic HIV medics assist doctors, clinical officers, and nurses by
providing the following services: basic triage, intensive adherence support, health education to
waiting patients, ARV drug refills for stable patients, phlebotomy, pharmacy inventory, and logistics
management. Expert clients also assist in patient triage including weighing, taking body temperature,
and measuring height as well as the mid upper arm circumference for assessing nutrition status. They
http://www.aidshealth.org/#/

4
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also assist with records management which includes chart retrieval and returns, filling of records such
as registers, inserting test results into patient files, and moving charts to and from clinician rooms.
In addition they help in transporting blood samples from lower health units to reference laboratory.
They also provide patient education and counseling and help track patients in care, telephoning
patients who have missed appointments as well as those who need review before the scheduled visit
date. They further assist with the cleaning and dusting of the clinic area.
d. Training and supervision: UC has a team comprising a medical doctor and nurses that conduct
training and visits to clinics in various parts of the country to provide supportive supervision to staff.
The day-to-day supervision of both HIV medics and expert clients is entrusted to nurses, since this is
the department they work with very closely. Additional support, mentorship, and training are availed
by the program nurse manager as well as training manager. The health workers also receive ongoing
training through clinical team meetings as well as site level continuing medical education (CME)
sessions.
The data in Table 5 are from the interviews of 92 HWs from UC comprising 50 PHWs (1 doctor, 9
clinical officers, 18 nurses, 10 counselors, 2 pharmacy workers and 10 lab workers); and 42 LHWs (22
expert clients, 12 HIV medics, and 8 counseling aides). It shows that when we combine UC-MOH with
UC-S, 100 percent (50/50) of PHWs and a majority of LHWs, 93 percent (39/42), reported having
undergone a specific training on ART care. Regarding specific skills, half or more of PHWs reported
training in any of the four key skills: prescribing, 50 percent (25/50), dispensing, 52 percent (26/50),
counseling, 62 percent (31/50), and health talk, 54 percent (27/50). A slightly higher proportion of
LHWs reported having been trained in the two skills of counseling, 71 percent (30/42) and health talk
about ART, 67 percent (28/42), which are the two roles most delegated to LHWs. It would have been
interesting to examine proportions trained by each specific cadre (e.g., clinical officers) but the sample
sizes of some cadres were too small for comparison. However, among PHWs nurses had a substantial
sample size (n = 18) and among these about three quarters were trained in prescribing (13/18) and about
two thirds in dispensing, counseling, and health talk (11/18) (data not shown). Thus these small numbers
suggest that a higher proportion of nurses (2/3) than other PHWs at UC (1/2) were trained in key skills.
The facility audits documented a wider variety of health workers at UC sites compared to Kitovu Mobile
sites, including doctors, clinical officers, nurses, counselors, pharmacy workers, and laboratory workers;
and lay health workers (expert clients, as defined above, and HIV medics). On the day of audit the UCMOH clinics had a lower number of patients, averaging 44 per clinic, compared to 94 patients per UC-S
clinic. The audits also showed that the work load per professional health worker was similar at both UCMOH and UC-S, 11 patients that day. The work load per LHW was however lower at UC-MOH than
UC-S clinics, nine patients compared to 15 patients.
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Table 5 UC providers reporting ART-care training
UC-MOH

UC-S

n = 34
n (Prop)

n = 16

Has received specific ART-care training

34 (1.0)

16

Topic of ART-care training:

Prescribing

17 (0.5)

8

Dispensing

18 (0.5)

8

Counseling

22 (0.6)

9

Health talk

21 (0.6)

6

n = 30
n (Prop)

n = 12

29 (1.0)

10

Prescribing

8 (0.3)

6

Dispensing

9 (0.3)

6

Counseling

23 (0.8)

7

Health talk

20 (0.7)

8

Professional HWs (doctors, clinical officers, nurses, counselors, pharmacy
workers, lab workers)

LHWs (Expert clients, HIV medics, counseling aides)
Has received specific ART-care training
Topic of ART-care training:

Data source: HW interviews; more than one response possible.

As Table 6 shows, in UC clinics there was a variation in the model of delegating clinical tasks. At UCMOH the facility audits documented that clinical review, which is conventionally the role of doctors and
clinical officers, was being performed by only clinical officers. Counseling and dispensing were conducted
by nurses, implying that in this model these tasks, which conventionally are the roles of counselors and
pharmacy workers, respectively, were delegated5 to nurses. The delegation of tasks at UC-S was similar
to UC-MOH except for clinical review, which during the facility audits was observed to be performed
by both doctors and clinical officers, suggesting that this task was not delegated. However, UC programs
reported that for some stable ART patients coming for ARV refills, the task of clinical review is sometimes
delegated to nurses and HIV medics.

Delegation of tasks does not always imply that the HW being delegated to is lower in rank, but it could mean that
the HW being delegated to is not conventionally the one designated to perform that role. For example delegation
of counseling from a counselor to a nurse does not imply that nurses are a lower rank to counselors—they are in
different professions each with its own hierarchical structure so they cannot be ranked against each other.

5
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Table 6 Tasks delegated at UC

Pre-clinical (registration,
triage, health talk, and vital
signs)
Clinical review
















LHW

Nurse

Counselor

Pharmacy

Clinical
officer

Doctor

LHW





Counseling
Dispensing

UC-S
Nurse

Counselor

Pharmacy

Clinical
0fficer

Doctor

UC-MOH

















 - Conventional performer of task;  - Observed performer of task
Data sources: Facility audits (n = 9)

The AIDS Support Organization (TASO)
TASO6 is a non-governmental organization that was among the first to provide HIV care and support
in Uganda and sub-Saharan Africa in 1987 and has provided ART to its patients in Uganda since 2004.
Their service statistics showed that as of June 2014 TASO had 91,218 current patients of whom 68,584
were on ART, including 13,394 who were new ART patients in 2013.
TASO uses a hierarchical structure of one national headquarter office working through four subnational offices to support the 11 service delivery centers. ART patients attending TASO-CDDP receive
monitoring by a visiting team of clinicians and counselors every six months.
How the ART task-shifting approach was developed
A review of program reports showed that to institute the CDDPs, TASO undertook the following
measures:
a. Training of expert clients in ART care: Each TASO center has community ART support agents
(CASAs) who are expert clients on ART and who were trained to mobilize other patients to attend
the drug distribution point and to provide counseling and monitoring of adherence to a maximum
of 10 patients within their locality. CASAs are ART patients who can read and write, and who are
selected by TASO with the consent of other patients residing in a specific community. These patients
are trained on basic information about ART and HIV/AIDS in general and given skills to conduct
a number of activities including refilling of ARVs, giving out CD4 results, counseling, and checking
hemoglobin levels. They are also equipped with bicycles, gumboots, and TASO T-shirts, bags, books,
and pens to facilitate their work.

http://www.tasouganda.org/

6
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b. Establishment of community outreach locations: When TASO decided to start CDDPs, the expert
clients were asked to consult with patients in their group to identify a venue in the community where
they could congregate to receive ARVs from a TASO team visiting from the central clinic. After the
sites were selected, about 30 patients were grouped in one community site which became a CDDP.
Each TASO center has about 30 CDDPs and the locations include schools, community halls, places
of worship, and sometimes just under a large tree.
c. Training counselors in ARV refill: At each TASO center there is a cadre of counselors (counseling
diploma holders) whose traditional role had been to provide counseling, including pre- and post-test
counseling and adherence counseling. When the CDDP model was introduced the counselors were
trained in dispensing ARV refills. They were also trained in conducting hemoglobin tests using test
strip technology to identify anemia as a sign of toxicity. Additionally, they were trained to conduct
pregnancy tests to identify early pregnancy since, at that time, the ARV Efavirenz was not considered
safe in early pregnancy (WHO 2012).
d. Process of the CDDP clinic: ART patients who had stabilized on medication were selected and downreferred to a TASO-CDDP of their choice to receive ARV refills on an ongoing basis. Each CDDP
was allocated one day every other month when the counselor would visit the outreach clinic to deliver
the ARV refills. In the morning of that date the counselor works with the pharmacy staff at the
central clinic to pack ARV refills for each patient for the given CDDP. The counselor then transports
these ARV packets in a car to the community outreach setting. At the outreach clinic the process
starts with a health education talk for all patients followed by a one-on-one consultation during
which the counselor asks about the patients’ well-being, conducts the hemoglobin test and pregnancy
test (for females), dispenses the ARVs, and provides adherence counseling. The counselor is assisted
by expert patients in providing this care. CDDP patients with medical and psychosocial issues are upreferred to TASO-C for the review after which they are down-referred to the TASO-CDDP to resume
ongoing ARV refill.
e. Supervision: Each CDDP care team (the counselor and the expert clients) is supervised by a doctor or
clinical officer and a nurse to ensure that the patient care is in line with TASO’s quality of care. The
supervising team moves among the CDDPs every six months observing the care provided, including
reviewing some patients and providing support as needed.
The data in Table 7 are from the HW interviews of 126 HWs from TASO comprising 89 PHWs (4
doctors, 13 clinical officers, 12 nurses, 41 counselors, 7 pharmacy workers, and 12 lab workers); and 37
LHWs (30 expert clients, 2 community health workers, and 5 counseling aides). It showed that in TASOCDDP combined with TASCO-C the majority of PHWs, 83 percent (74/89), and of LHWs, 84 percent
(31/37), reported having undergone training on ART care. Regarding specific skills: about half of PHWs
reported training in any of the four key skills: prescribing, 39 percent (35/89); dispensing, 46 percent
(41/89); counseling, 56 percent (50/89); and health talk, 40 percent (36/89). Among the LHWs there
was a wide variation in the proportion reporting having been trained in the two skills most delegated to
LHWs—49 percent (18/37) trained in counseling compared to 68 percent (25/37) trained in health talk.
It would have been interesting to examine proportions trained by each specific cadre (e.g., nurses) but the
sample sizes of some cadres were too small for comparison. However, among PHWs, counselors had a
substantial sample size (n = 41); among these 29 percent (12/41) were trained in prescribing, 51 percent
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(21/41) in dispensing, 85 percent (35/41) in ARV counseling, and 49 percent (20/41) in health talk. Of
particular interest are the counselors in the TASO-CDDP model who are responsible for dispensing ARV
refills, of whom only 60 percent (12/20) reported training in dispensing of ARVs (data not shown).
Table 7 TASO providers reporting ART-care training
TASO-CDDP

TASO-C

n = 42
n (Prop)

n = 47
n (Prop)

Has received specific ART-care training

34 (0.8)

40 (0.9)

Topic of ART-care training:

Prescribing

16 (0.4)

19 (0.4)

Dispensing

20 (0.5)

21 (0.4)

Counseling

23 (0.6)

27 (0.6)

Health talk

16 (0.4)

20 (0.4)

n = 26
n (Prop)

n = 11

Professional HWs (doctors, clinical officers, nurses, counselors,
pharmacy workers, lab workers)

LHWs (Expert clients, CHWs, counseling aides)
Has received specific ART-care training
Topic of ART-care training:

21 (0.8)

10

Prescribing

0 (0.0)

2

Dispensing

9 (0.3)

2

Counseling

10 (0.4)

8

Health talk

19 (0.7)

6

Data source: HW interviews; more than one response possible.

The facility audit data showed that the 10 CDDPs observed served an average of 56 patients per clinic,
compared to the central clinics that served an average of 119 patients per clinic on the day of observation.
There were 38 professional health workers and 10 LHWs documented at the 10 CDDPs altogether, while
at the central clinics there were 102 professional health workers and 19 LHWs. Thus the daily work load
per professional health workers was higher at the CDDP clinics (15 patients) compared to the central
clinic (6 patients). The workloads for lay HWs at both the CDDP and the central clinics were quite high,
56 and 32 respectively, suggesting that each lay HW spent little time with each patient, probably carrying
out only simple tasks like triage.
Table 8 shows that at the TASO-CDDP sites, clinical review—which is conventionally supposed to be
performed by doctors and clinical officers—was documented in the facility audits as being performed
by nurses. Counseling—conventionally supposed to be performed by counselors—was being performed
by LHWs. Dispensing of ARVs—a conventional role of pharmacy workers—was being carried out by
counselors assisted by LHWs. These data imply that all ART care tasks at TASO-CDDP, a highly taskshifted model, were delegated from the providers who were conventionally supposed to perform them to
other health workers.
It is further shown that at TASO-C, clinical review was performed by both doctors and clinical officers
who are conventionally supposed to perform this task. Similarly, dispensing of ARVs was being performed
by pharmacy workers, the cadre that is supposed to do this job. Counseling was being performed by
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counselors and LHWs. Thus, at TASO-C, a minimally task-shifted model, there was no delegation of
clinical review and dispensing while there was some delegation of counseling to LHWs.
Table 8 Tasks delegated at TASO

Pre-clinical
(Registration, triage, health
talk, and vital signs)





Dispensing














LHW

Nurse

Counselor

Pharmacy





Counseling

Clinical
officer

LHW



Clinical review

Doctor

TASO-C
Nurse

Counselor

Pharmacy

Doctor

Clinical
officer

TASO-CDDP










 - Conventional performer of task;  - Observed performer of task

Overview of delegation of tasks
Figure 3 examines delegation of tasks for the three ASOs combined. As expected, it shows that tasks
tended to be delegated from the health workers at the apex of the medical order—doctors and clinical
officers—rather than to them. For the mid-level health workers—nurses and counselors—there was
similar likelihood of tasks being delegated from them and to them. As for providers toward the bottom of
the rank—expert clients and HIV medics—there was an inclination to delegate tasks to them, rather than
from them.
Figure 3 Overview of delegation of tasks

Number of HWs

40

38

30

26

24

20
15

15
12

12

10
5

4
1
0

Doctor
(n = 5)

13

14

7

6

6
3

0
Clinical officer
(n = 23)

Nurse
(n = 34)

Delegated from

Counselor
(n =54)

Delegated to

Expert client
(n = 76)

3

HIV medic
(n = 12)

Neither or missing

Data source: Health worker interviews (n=268)
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However, it is notable that doctors, who are at the apex, also reported that some tasks were delegated to
them. Similarly, expert clients and HIV medics, who are at the bottom ranks, also reported that some
tasks were delegated from them. Inquiry from program managers revealed that doctors could get ART
care tasks delegated to them by other doctors who are more senior. The program managers also reported
that HIV medics and expert clients could delegate some simple tasks, such as triage, to ordinary ART
patients to assist on a busy day.
The pattern of delegation emerging from HW interviews demonstrated in Figure 1 seems to confirm the
pattern that emerged from facility audits, shown in Tables 4, 6 and 8. Both data sources show that the
two mid-level cadres (counselors and nurses) were as likely to report tasks being delegated from them as
tasks being delegated to them. For example, the facility audits showed that the role of nurses to perform
pre-clinical care was delegated to LHWs in all the models, while nurses were having the roles of clinical
assessment, counseling, and dispensing being delegated to them in some models. Similarly, at TASOCDDP, facility audits showed that counseling was delegated from counselors to LHWs while counselors
got the role of dispensing delegated to them.
Another way to look at the pattern of delegation is by type of task-shifting model (Figure 4). The data
show that in the community-based models (Kitovu Mobile and TASO-CDDP) the HWs were more likely
to report being delegated to (60 percent and 51 percent respectively) than to report being delegated from
(38 percent and 32 percent respectively). In conformity, at UC-S, a facility-based model, the HWs were
more likely to report being delegated from (29 percent) than being delegated to (18 percent). However, at
TASO-C and UC-MOH no trend emerges. Thus, excluding TASO-C and UC-MOH, the data suggest
that in the community-based settings the HWs were more likely to be delegated to compared with the
facility-based clinic.
Figure 4 Pattern of delegation by model of care (HW interviews)
70
60

60

51

Percentage

50
40

38

38
27

30

25

32

29

20

40

18

10
0

Kitovu Mobile
(n = 40)

UC-MOH
(n = 60)

UC-S
(n = 28)

Delegated from

TASO-CDDP
(n = 72)

TASO-C
(n = 68)

Delegated to
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PATIENT-LEVEL OUTCOMES

This section focuses on the implications of task-shifting on patient level outcomes.

Client perceptions
Table 9 compares data from the community-based settings (Kitovu Mobile and TASO-CDDP) to the
facility-based clinics (UC-S, UC-MOH, and TASO-C) with regard to three patient outcomes: ARV
knowledge, recall of services received, and client satisfaction. In both the community-based and the
facility-based clinics, only about one-third of the patients gave correct responses to the ARV knowledge
questions. The data show that the proportion recalling these key services was marginally higher in the
facility-based (66 percent) compared to the community-based clinics (59 percent) (p < 0.05).
Table 9 Self-reported patient-level outcomes in all models (Client exit survey)
Respondents

Community-based
n = 1,166
Prop

Facility-based
n = 1,108
Prop

p-value

ARV knowledge index

0.32

0.35

> 0.05

Recall of key ARV services index

0.59

0.66

< 0.05

Satisfaction index

0.90

0.93

< 0.05

The data show that client satisfaction was quite high overall and marginally higher at the facility-based (93
percent) compared with the community-based clinics (90 percent) (p < 0.05).
In summary, these findings suggest that client knowledge about ARVs is low in all the clinics. However,
patient recall of receiving key elements of discussion about ARVs with the provider in the clinic that
day and client satisfaction were marginally higher at the facility-based compared to the communitybased settings. This difference in recall, while statistically significant, was programmatically marginal at 7
percentage points, and it is important to note that client satisfaction was quite high in both communitybased and facility-based clinics.
Retrospective analysis of routine service data
Table 10 shows the patient histories that were collected from the three ASOs: 1,944 patient histories were
collected from five TASO facilities, 198 patient histories from two Uganda Cares sites, and 81 patient
histories were obtained from Kitovu Mobile. Overall, TASO patients were more frequently female;
Uganda Cares patients were younger and were more evenly distributed by gender than TASO patients.
Patients of Kitovu Mobile were, on average, five years older than TASO patients and eight years older
than Uganda Cares’ patients.
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Table 10 Site descriptions
Organization
TASO

# female
patients

# male
clients

Median
patient age,
yrs (IQR)

524

334

190

35 (30–42)

Central-CDDP

389

267

122

35 (29–42)

Central-CDDP

455

297

158

38 (33–45)

Masindi

Central-CDDP

220

154

66

36 (30–42)

Rukungiri

Central-CDDP

356

218

138

39 (33–49)

1,270 (65.3%)

674 (34.7%)

36 (30–44)

Site name

Model used

Entebbe

Central-CDDP

Gulu
Jinja

TOTAL
Uganda
Cares

# total
clients

1,944

St. Balikudembe

Central

129

69

60

33 (28–40)

Nakawa Market

Central

69

38

31

34 (29–40)

TOTAL
Kitovu
Mobile

N/A

Community
Outreach

Grand Total

198

107 (54.1%)

91 (45.9%)

33 (28–40)

81

43 (53.1%)

38 (46.9%)

41 (34–49)

2,223

1,429 (63.8%)

809 (36.2%)

36 (30–44)

IQR is interquartile range

Service utilization, drug adherence, and retention in care
Service utilization: Data were cleaned and complete longitudinal service histories were compiled for 2,223
ART patients who initiated treatment during the review period. At the time of ART initiation, median
patient age was 36 years. Nearly two-thirds (64 percent) of the study population was female. As described
in Table 10, patients attended an average of 13.3 drug refill visits during the review period, spent 49.4
days between refill visits, and received sufficient ARV medication to cover their treatment for 50.9 days.
Table 11 Service utilization—All sites
Per-patient averages

Total
n = 2,223

Median time in care—days per patient (IQR)

801 (741–852)

Mean time in care—days per patient (SE)

686 (270.7)

No. ART refill visits (SE)

13.3 (5.4)

Avg. period between patient visits—days (SE)

49.4 (17.2)

Avg. days covered by drugs dispensed per visit—days (SE)

50.9 (10.7)

SE is standard error

Table 12 shows that patients of all three organizations remained in care for a similar amount of time, with
averages ranging from 671 to 730 days. TASO patients on average spent 51 days between visits, attending
an average of 12.7 visits in the 24 months of follow-up. At each visit, they received sufficient medication
to cover an average period of 52 days before a refill was needed. Likewise, patients of Uganda Cares spent
39 days between visits, where they received 47 days-worth of medication. Kitovu Mobile appeared to
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be dispensing insufficient quantities of medication; although their patients spent an average of 35 days
between visits, on average, they only received enough medication to last 30 days.
Table 12 Service utilization—by provider
Per-patient averages

Kitovu Mobile
n = 81

UC
n = 198

TASO
n = 1,944

n (%)

n (%)

n (%)

Days retained in care (SE)

815 (24.9)

812 (21.2)

795 (6.11)

Mean days-in-care, per-patient (SE)

729.8 (224)

671.4 (297.7)

686.4 (269.5)

No. ART refill visits attended (SE)

21.3 (6.7)

17.5 (7.7)

12.7 (4.7)

Avg period between patient visit—days (SE)

35.0 (11.0)

39.0 (16.4)

51.0 (16.9)

Avg. drugs dispensed per visit—days (SE)

29.5 (9.3)

46.5 (19.2)

52.2 (8.1)

Drug adherence: Though patients were typically dispensed quantities of medication that were sufficient to
last until their next refill visit, treatment gaps were common. Table 13 shows that 40 percent of patients
had one or more gaps in treatment lasting at least 45 days, and many patients had multiple gaps. Gap
duration varied widely, ranging from 48 to 613 days, with patients spending an average of 112.0 days
(95% CI: 107.9–116.1) away from the health facility before returning to care. Based on the available
data, it was not possible to determine whether patients obtained any medication from an external source
during treatment gaps. After 24 months of follow-up, 54.5 percent of patients had received sufficient
ARV medication to cover at least 95 percent of their expected treatment. In other words, based on
available documentation of dispensed drugs, half of all clients attending the TASO, UC, and Kitovu
Mobile sites surveyed did not receive sufficient medication to for their treatment.
Table 13 Treatment gaps and drug adherence—all sites
95% CI

Outcome (n = 2,223)
Patients w/ at least 1 treatment gap > 45 days

896 (40.3%)

38.2%–42.3%

Mean treatment gap duration—number of days (SE)

112 (2.1)

107.9–116.1

1,211 (54.5%)

52.4%–56.5%

Patients achieving ≥ 95% drug adherence
CI is confidence interval

Table 14 shows that approximately 40 percent of patients from all providers had at least one gap in
treatment that exceeded 45 days. The mean duration of these gaps ranged from 89 days at Kitovu Mobile
to 113.6 days at TASO. However, only 18.5 percent of Kitovu Mobile patients attained greater than 95
percent drug adherence during their time in treatment. At TASO and Uganda Cares sites, 54 percent and
71 percent of patients, respectively, reached this benchmark.

Table 14 Treatment gaps and drug adherence—by provider
Kitovu Mobile
n = 81

UC
n = 198

TASO
n = 1,944

Patients with ≥1 treatment gap

32 (39.5%)

85 (42.9%)

778 (40%)

Mean treatment gap duration—number of days (SE)

88.7 (50.5)

108.2 (67.7)

113.6 (62.2)

Patients achieving ≥95% drug adherence

15 (18.5%)

140 (70.7%)

1,059 (54.5%)

Outcome

Retention: There were four possible outcomes relating to the retention of ART patients: death, transfer
to another facility, loss to follow-up, and completion of the follow-up period. In the clinic records, only
death and patient transfer were documented. Patients who were in default as of December 31, 2012 were
considered lost to follow-up unless the facility records specified that the patient had transferred to another
facility or had died. Table 15 shows that of 2,223 patients reviewed at all sites, 1,667 patients (75 percent)
were actively retained in care after 24 months, 16 patients (0.7 percent) had transferred to another facility,
and six patients (0.3 percent) had died. The remaining 24 percent of patients (534) had defaulted on
their care without resuming treatment by December 31, 2012, and had no final outcome documented
in their records; all were deemed lost to follow-up. However the caveat must be made that the quality
and completeness of final patient outcome records varied by organization and facility. Therefore, it was
not possible to ascertain whether any lost to follow-up patients may have actually died or transferred
to another facility. From the perspective of improving drug adherence, facilities should consider any
defaulting patients to be in need of support until the patient resumes care, or an ultimate outcome can be
determined.
Kitovu Mobile had the most complete records on client outcomes. As shown in Table 15, by the end of
the data collection period, 17 Kitovu Mobile patients had left the cohort. Of these, six had died, and
another six had transferred to other facilities. The remaining five patients had no recorded outcome, thus
they were categorized as lost to follow-up. Records from TASO indicated that 479 patients were not
retained in care. Of these, records indicated that only 10 had transferred to other facilities and no data on
any patient deaths were recorded. As the remaining 469 had no documented outcomes, we categorized
all of them as lost to follow-up. UC provided no documented outcomes for any patients who were not
retained, therefore all 60 non-retained patients are treated as lost to follow-up.
Table 15 Outcomes at 24 months
Ultimate patient outcomes

Kitovu Mobile
n = 81

UC
n = 198

TASO
n = 1,944

All sites
N = 2,223

n (%)

n (%)

n (%)

N (%)

Lost to follow-up

5 (6.2%)

Transfer out

6 (7.4%)

Retained
Died

64 (79.0%)
6 (7.4%)

60 (30.3%)
0
138 (69.7%)
0

469 (24.1%)

534 (24.0%)

10 (0.51%)

16 (0.7%)

1,465 (75.4%)

1,667 (75%)

0

6 (0.3%)

Table 16 shows that retention was highest during the first six months after a patient’s initiation onto ART
and lowest at 24 months. At the bottom of Table 16, the data on loss to follow-up shows that for all sites,
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patients who were ultimately lost to follow-up spent a median of 217 days in care, and completed an
average of five visits. Nearly a quarter of all patients (23.7 percent, n = 127) were lost to follow-up within
30 days of initiating ART; 15.7 percent (n = 84) completed only one visit before dropping out. Nearly a
quarter of all loss to follow-up at TASO (24.3 percent) and UC (21.7 percent), occurred within the first
30 days after initiation; 13.3 percent of UC patients, and 16.2 percent of TASO patients completed only
their initial ART visit before dropping out. Kitovu Mobile lost no patients after the first visit, nor within
the first 30 days. A chi-square test indicates that there was significant variability in patient retention
between the three providers (p < 0.0001).
Table 16 Retention and loss to follow-up by duration
Kitovu Mobile
n = 81

UC
n = 198

TASO
n = 1,944

All sites
N = 2,223

n (%)

n (%)

n (%)

N (%)

No. patients retained after 6 months

77 (95.1%)

169 (85.4%)

1,727 (88.8%)

1,973 (88.8%)

No. patients retained after 12 months

76 (93.8%)

161 (81.3%)

1,632 (84.0%)

1,869 (84.1%)

No. patients retained after 18 months

72 (88.9%)

147 (74.2%)

1,572 (80.9%)

1,691 (76.1%)

Client retention

No. patients retained after 24 months
Loss to follow-up
Median time to loss to follow-up—days (IQR)

70 (86.4%)

138 (69.7%)

1,475 (75.9%)

1,683 (75.7%)

Kitovu Mobile
n=5

UC
n = 60

TASO
n = 469

All sites
N = 534

374 (224–495)

286.5 (4 –473)

210 (31–465)

217 (34–467)

Median no. visits completed (IQR)

7 (6–12)

5 (2–9)

5 (2–10)

Patients lost to follow-up ≤30 days (%)

0

13 (21.7%)

5 (3–12.5)

114 (24.3%)

127 (23.8%)

Patients lost to follow-up after 1 visit (%)

0

8 (13.3%)

76 (16.2%)

84 (15.7%)

Figure 5 depicts retention in care at six-month intervals for each of the three organizations. Retention in
ART care at 24 months was 86 percent at Kitovu Mobile, 75.9 percent at TASO, and 70 percent at UC.
This variation in retention rates among the three organizations is also seen at the 6, 12, and 18 months
intervals.
Factors associated with loss to follow-up: Using chi-squared tests, we examined associations between loss to
follow-up and other related factors. The most prominent risks for loss to follow-up were sex, being below
median age, and primary service location. Significant associations are detailed in Table 17. Due to the
much larger size of TASO’s cohort, most associations were observed among TASO clients. Males were 1.6
times more likely than women to be lost to follow-up (p < 0.0001); patients under 36 years of age were
1.3 times more likely to be lost to follow-up, though significance was marginal (p = 0.036). Chi-squared
tests for homogeneity indicated that there were significant differences in loss to follow-up between the five
TASO facilities that we surveyed (p = 0.001).
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Figure 5 Comparison of retention in care at the three ASOs
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Table 17 Factors associated with loss to follow-up
Bivariate associations

OR

p-value

95% CI

Sex (n = 1,944)
Female

1.00

—

—

Male

1.61

< 0.0001**

[1.313–2.015]

≥ 36 years

1.00

—

—

< 36 years

1.25

Age (n = 1,944)
0.036*

[1.014–1.538]

0.056

[0.972–3.826]

Location of primary clinic
UC (n = 198)
St. Balikudembe

1.00

Nakawa Market

1.93

TASO (5 locations; n = 1,944)

0.001**

Rukungiri

1.00

—

Gulu

1.01

0.97

Jinja

1.26

0.17

Masindi

1.24

0.29

Entebbe

1.75

0.0006**

—
[0.703–1.443]

*p < 0.05
**p < 0.001
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Associations between task- and site-shifting and patient retention in care: Only TASO provided data from
ART services delivered to patients through both their central facilities and community-based service
points. We assessed relationships between CDDP attendance and patient retention rates using multiple
logistic regression. Table 18 describes CDDP utilization among the subset of 1,757 TASO patients
who were sufficiently stabilized in their care, and thus eligible to receive services at a CDDP (i.e., had
completed at least four refill visits). One third were male, and the median age was 37 years; 1,636 patients
attended at least one CDDP-based refill visit, while 121 patients attended only facility-based refill visits.
Age and mean number of refill visits were significantly associated with ever using a CDDP: older patients
were significantly more likely to have ever visited a CDDP; patients who ever visited a CDDP completed
significantly more refill visits.
Table 18 Bivariate analysis of TASO patient CDDP utilization
No CDDP attendance
n (row %)

Attended CDDP
n (row %)

121 (6.9)

1,636 (93.1)

Male (n = 586: 33%)

36 (6.1)

550 (93.9)

Female (n = 1,171: 67%)

85 (7.3)

1,086 (92.7)

< 37 years (n = 808: 49.1%)*

69 (8.5)

739 (91.5)

≥ 37 years (n = 949: 50.9%)*

52 (5.5)

897 (94.5)

26 (5.9)

412 (94.0)

Among stable TASO patients
Stable patients
(# visits ≥ 4, n = 1,757)
Sex

Age

Location of primary clinic
Entebbe (n = 438)
Gulu (n = 364)

28 (7.7)

336 (92.3)

Jinja (n = 416)

36 (8.7)

380 (91.3)

Masindi (n = 215)

14 (6.5)

201 (93.5)

Rukungiri (n = 324)

17 (5.2)

307 (94.8)

Mean number of drug refill visits completed
12 months [95% CI]**

6.5 [6.2–6.9]

7.3 [7.3–7.4]

18 months [95% CI]**

8.1 [7.5–8.6]

10.2 [10.1–10.2]

10.0 [9.1–10.9]

13.8 [13.7–14.0]

12 months (%)**

67/121 (55.3)

1,559/1636 (95.3)

18 months (%)**

58/121 (47.4)

1,510/1636 (92.3)

Overall (%)**

52/121 (42.3)

1,419/1636 (86)

Total [95% CI]**
Proportions of patients retained

*Significant difference between groups who did/did not attend any CDDP-based service ( p < 0.05).
**Significant difference between groups who did/did not attend any CDDP-based service ( p < 0.001).

Stable TASO patients who received any services through a CDDP were significantly more likely to be
retained at 12 (OR: 16.3; 95% CI: 10.3–25.9) and 18 months (OR: 13.0; 95% CI: 8.5–20.0) than
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patients who attended no CDDP-based visits. To examine whether intensity of exposure to CDDPbased services affected rates of retention and drug coverage, we first attempted to account for behavioral
biases arising from differences in refill visit attendance between clinic-only clients and those who utilized
CDDPs. Via Student’s t-test, we determined that among the subset of 1,568 clients who attended at least
10 refill visits, any differences in the average total number of refill visits that each client completed—
regardless of whether they had attended a CDDP (n = 1,509), or received only clinic-based services
(n = 59)—were not significant (p > 0.34). Among this subset, 111 were lost to follow-up, three had
transferred, and 1,454 were retained after 24 months.
Among this subset of clients, we constructed a three-level exposure variable. As this population had
considerable variability in their total number of refill visits attended (min = 10, max = 31), we based the
exposure variable on the proportion of total refill visits that an individual client completed at a CDDP.
For this sub-population, median CDDP exposure was 66 percent. Thus, the 749 clients who attended
fewer than 66 percent of their total visits at a CDDP were classified as having low CDDP exposure, while
the 760 clients who attended more than 66 percent of their total refill visits at a CDDP were classified as
high-exposure. The third level of exposure comprised 59 clients who had no CDDP exposure.
Finally, we included this exposure variable in a logistic regression model controlling for age, sex, primary
service location, and total number of visits completed during 24 months of follow-up. This analysis
indicates that clients with high exposure to CDDP services were significantly more likely to be retained
after 24 months than clients with low CDDP exposure (OR: 4.15, 95% CI: 1.83–9.41). However,
differences in retention between low-exposure and no-exposure groups were not significant (OR=1.95,
95%CI: 0.89–4.25). Among the 1,454 TASO clients who completed at least 10 visits and were retained
after 24 months, CDDP utilization had no significant association with achieving 95 percent drug
coverage during their time in care.

HEALTH SYSTEMS OUTCOMES

This section presents findings regarding the implications of task-shifting on two key health systems
outcomes—quality of care and cost of care.

Observed performance of providers
Table 19 shows that the vast majority of the sessions observed were repeat ART visits. The type of
provider observed varied by clinic, reflecting the distribution of providers who conducted one-on-one
consultation sessions with patients, since only clinical- or counseling-type of consultation sessions were
selected for observation. For Kitovu Mobile the majority of sessions observed were conducted by a nurse;
at UC-MOH the majority was split between the clinical officer and nurse; at UC-S the majority was split
between doctors, clinical officers, and HIV medics; at TASO-CDDP the majority of sessions observed
were conducted by the counselor; while at TASO-C the majority were conducted by the clinical officer.
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Table 19 Characteristics of service sessions observed for CPI
Kitovu
Mobile
Number of health facility sites
Number of sessions observed
Average number of sessions per site

UC-MOH

UC-S

TASOCDDP

TASO-C

4

6

3

10

5

203

310

136

498

271

51

52

45

50

54

%

%

%

%

%

Type of patient visit
First visit

0.5

1.6

0.0

0.0

6.3

99.5

98.4

100.0

100.0

93.7

Doctor

0.0

13.9

26.6

1.0

5.5

Clinical officer

5.4

42.3

28.8

14.9

65.7

Repeat visit
Type of provider

94.6

37.7

8.9

10.2

3.7

Counselor

Nurse

0.0

0.0

0.0

66.5

16.6

Lab tech

0.0

0.0

0.0

0.6

1.5

Lab assistant

0.0

0.0

0.0

2.4

3.3

Pharmacy worker

0.0

0.0

0.0

0.0

2.6

Counseling assistant

0.0

0.0

0.0

1.2

0.0

CHW

0.0

0.0

0.0

0.6

0.0

Expert client

0.0

0.0

0.0

2.4

0.4

HIV medic

0.0

6.1

35.5

0.0

0.4

Other

0.0

0.0

0.0

0.2

0.0

Table 20 shows that while the performance of assessment of the patients was 66 percent to 74 percent
and the performance of addressing complaints was 70 percent to 89 percent, there was a relatively low
performance with regard to adherence counseling (42 percent to 55 percent), and counseling about side
effects (30 percent to 42 percent). To examine how the quality of care varies with the level of task-shifting
we compared the quality of care data between the facility-based clinics (TASO-C, UC-MOH, and UC-S)
and the community-based clinics (Kitovu Mobile and TASO-CDDP). Table 20 shows that the providers
at the facility-based clinics performed significantly better in addressing the patients’ complaints compared
to community-based settings (p < 0.01). However, there was no significant difference between these two
types of clinics in the performance of the other key ART care tasks (p > 0.05).
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Table 20 Comparison of performance of providers between community-based and
facility-based clinics (CPI observations)
Communitybased
n = 696

Facilitybased
n = 714

p-value

Prop

Prop

Assessment of patient (weighing; asking about complaints; exploring issues)

0.66

0.74

> 0.05

Adherence counseling (asking about: missed dose, challenges in adherence,
and family support; discussing adherence on ARVs received today)

0.42

0.55

> 0.05

Side effects counseling (asking about side effects; discussing signs and
symptoms of side effects and what should be done in case of side effects)

0.30

0.42

> 0.05

Addressing complaints (providing solutions or referrals for each of the
complaints raised by patient)

0.70

0.89

< 0.01

In summary, while there was no significant difference between the two levels of task-shifting in provider
performance of most of the key ART care tasks observed, the performance of providers in addressing
patients’ complaints was significantly lower at the community-based than at the facility-based clinics.
As mentioned before, Uganda Cares has a unique type of LHW, the HIV medic that was created for
task-shifting of ART care. Indeed as Table 21 shows, among the sessions observed the HIV medic was
the provider in 67 sessions while in 382 sessions the providers were other health workers: doctors (n =
82), clinical officers (n = 167) and nurses (n = 133). Comparison of performance shows that there was no
statistically significant difference between the performance of HIV medics and the other health workers in
any of the key tasks in ART care (p > 0.05).

Table 21 Comparison of performance of tasks at UC clinics by type of HW
(CPI observations)
HIV medics
n = 67

Other HWs
n = 382

p-value

Prop

Prop

Assessment of patient (weighing; asking about complaints; exploring
issues)

0.85

0.93

> 0.05

Adherence counseling (asking about: missed dose, challenges in
adherence, and family support; discussing adherence on ARVs
received today)

0.60

0.62

> 0.05

Side effects counseling (asking about side effects; discussing signs
and symptoms of side effects and what should be done in case of
side effects)

0.32

0.35

> 0.05

Addressing complaints (providing solutions or referrals for each of
the complaints raised by patient)

0.96

0.98

> 0.05
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Time spent
The calculation of time spent with each patient was based on the provider of the main consultation
session that, we assumed, had to see every patient attending the clinic. As documented in the facility
audits, this provider differed across the five models within the three ASOs described earlier.7 Based on this
assumption, the time available for each patient with the provider of the main consultation ranged from
9 to 27 minutes (Table 22). While no gold standard exists, it is our opinion that patients spent sufficient
time with providers of main consultation sessions within each of these five models.
Table 22 Time spent on clinical review (Facility audits)

a. Median clinic duration from open to close
(min)
b. Total patients seen on day of audit

Kitovu
Mobile

UC-MOH

UC-S

TASOCDDP

TASO-C

288

392

465

227

549

196

266

283

561

594

Nurse (n =
13)

Dr. or CO
(n = 9)

Dr. or CO
(n = 6)

Counselor
(n = 22)

Dr. or CO
(n = 27)

d. Number of patients per provider of the
main consultation session (= b ÷ c)

15

30

47

26

20

e. Average minutes per client for clinical
review (= a ÷ d)

19

13

10

9

27

c. Cadre responsible for the main
consultation session

Table 23 shows that the overall time spent by each patient at the clinic ranged from 48 minutes at UC-S
to 3 hours and 45 minutes at Kitovu Mobile. The time that was spent on waiting ranged from 33 minutes
at UC-S to 3 hours and 15 minutes at Kitovu Mobile. The contact time with clinic staff appears to be
within the same order of magnitude across the five models (15 to 29 minutes).
Table 23 Median time spent per patient (Time-motion study)

Median overall time spent at clinic (min)
Median total contact time with all clinic staff
(min)

Kitovu
Mobile

UC-MOH

UC-S

TASOCDDP

TASO-C

225

128

48

200

221

15

20

18

18

29

Median total waiting time (min)

205

102

33

170

185

Percentage of total patient time spent with
a clinic staffer

6.7%

15.6%

37.5%

9%

13.1%

The five models are as follows: TASO has two models—TASO Central (TASO-C), which is facility-based, and
TASO Community Drug Distribution Points (TASO-CDDP), which is a community outreach program. Uganda
Cares has two models, both of which are facility-based—Uganda Cares Stand-alone (UC-S) which is operated at
clinics owned by UC, and Uganda Cares MOH (UC-MOH), which is operated at MOH clinics. Kitovu Mobile has
only one model—a community outreach program.

7

Retrospective review of task-shifting community-based programs supporting ARV treatment and retention in Uganda ■ 41

Thus, in most of the models patients spent a long time at the clinic, most of which was spent waiting
rather than in contact with providers. However, it is notable that UC-S has much shorter patient
waiting times than other models and is worth exploring further to identify possible best practices in time
management at UC-S that can be replicated.

Cost per visit and cost per client
Table 24 summarizes the 2012 total annual ART-related expenditure, the cost per client visit, and annual
cost per client in USD. Table 24 also shows the average number of visits per client per year across the
three models. In particular, clients at Kitovu Mobile made an average of nine visits to the Kitovu Mobile
outreach locations for ART care, while TASO clients made an average of about five visits, and UC clients
made about seven visits, annually. The average cost per visit was $38 for UC, $45 for Kitovu Mobile, and
$74 for TASO clients. The average annual cost per client was $404 for Kitovu Mobile, $332 for TASO,
and $257 for UC clients. The average cost per client for all three organizations was $331 and varied across
the four TASO centers and four UC clinics.
Table 24 Average cost per visit and annual cost per client across the 3 models (2012)
Total
expenditure
(USD)

Total
ART
clients

Total
ART
visits

Average
annual
visits/
client

Average
cost per
ART visit
(USD)

Annual
cost per
ART
client
(USD)

$560,756

1,387

12,510

9.0

$45

$404

Model

Location

Kitovu
Mobile

Rural—
Southwestern region

TASO

Rural—Gulu

$2,094,695

6,969

28,654

4.1

$73

$301

Rural—Rukungiri

$1,944,096

4,602

27,693

6.0

$70

$422

Semi-Urban—Jinja

$1,969,940

5,454

32,233

5.9

$61

$361

Semi-Urban—
Entebbe

$1,744,231

6,329

23,461

3.7

$74

$276

OVERALL COST

$7,752,962

22,814

112,041

4.8

$69

$332

Uganda
Cares

Urban—
St. Balikudembe

$791,009

2,498

12,636

5.1

$63

$317

Urban—
Nakawa Market

$190,222

530

6,076

11.5

$31

$359

Rural—Lyantonde

$272,841

1,250

10,345

8.3

$26

$218

Rural—Kalisizo

$274,717

1,669

11,420

6.8

$24

$165

$1,528,789

5,947

40,477

6.8

$38

$257

OVERALL COST

Table 25 shows the distribution of costs for each model. For Kitovu Mobile, ARV supplies comprised
47 percent of the total cost, personnel was 25 percent, operational expenses were 15 percent, 11 percent
was used to procure non-ARV drugs, and 2 percent was paid to ART-related lab services. TASO’s cost
distribution was fairly similar to Kitovu Mobile, with 44 percent attributed to ARV drugs, 21 percent
attributed to personnel, 15 percent attributed to non-ARV drugs, 14 percent attributed to administrative
expenses, and 6 percent spent on lab tests. UC’s cost distribution was different from both Kitovu Mobile
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and TASO. In particular, UC’s ART drug-related expenses accounted for 66 percent of the total cost,
followed by lab tests (13 percent), personnel (9 percent), administrative (8 percent), and non-ARV drugs
(4 percent).
Table 25 Cost distribution across 5 cost components (2012)
Model

Personnel
$ (%)

ARV
supplies
$ (%)

Non-ARV
medical
supplies
$ (%)

Laboratory
$ (%)

Administrative
costs
$ (%)

Total US $
$ (%)

Kitovu
Mobile

$140,529

$260,641

$59,439

$86,996

$560,756

25.1%

46.5%

10.6%

2.3%

15.5%

100.0%

TASO

$1,655,930

$3,399,418

$1,145,544

$477,737

$1,074,333

$7,752,962

21.4%

43.8%

14.8%

6.2%

13.9%

100.0%

$199,366

$121,500

$1,528,789

13.0%

7.9%

100.0%

Uganda
Cares

$135,106
8.8%

$1,007,376
65.9%

$65,441
4.3%

$13,150
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LIMITATIONS
OVERALL STUDY LIMITATIONS

In order to infer conclusions about the effect of task-shifting on health outcomes, an ideal study design
should have involved at least a two-arm comparison between task-shifted and not task-shifted services.
In addition, cost data should have included financial, economic, and opportunity costs incurred by
both providers and clients. To date at least three meta-analyses (referenced in the discussion) have been
published on the subject of ART task-shifting. The inclusion criteria for studies into these analyses have
tended to be: a randomized control trial comparing one provider against another of a different level of
qualification or comparing one level of health facility; or a cohort design with a baseline measurement
followed by the introduction of a task-shifting approach and then an endline measurement. However,
our study is a descriptive study examining different models of task-shifting that were designed, not for
comparison, but for increasing access to ARVs by delegating some tasks to lower level HWs and lower
level health care settings. The aim of our study was to capture, to the extent possible, the real life situation
under which ASOs are making decisions to increase access to ART using less costly, more available
space and personnel and what sort of outcomes can be associated with these decisions. In this effort we
encountered another limitation—the retrospective services statistics and financial data had not been kept
in a manner intended for a study but rather for practical use in routine service delivery and accounting
respectively. This resulted in delays in the study timeline due to the need for data cleaning and data-reentry in some cases. For this reason, this study which examined data for the period 2010 to 2012 is being
published several years later and may not adequately influence the fast-moving global trend, as shown in
the literature, towards adoption of ART task-shifting as a standard of care. However, we are hopeful that
our data will be useful in the continued refinement of task-shifting.
In addition, there are inherent organizational and structural differences in the task-shifting services
studied. Based on the descriptions in the programs annual reports, five fairly distinct models of taskshifting emerged. However, given the differences in structures, staffing, and other resources available in
each of these models, it may not be prudent to subject them to a rigorous comparison.

LIMITATIONS OF MANAGEMENT INFORMATION SYSTEM DATA
A number of limitations should be noted in interpreting the findings on retention and ARV adherence
that were derived from patient records. The quality of the data contained in the patient health records
varied widely by facility and organization, resulting in several important gaps:

1. The records of many patients were incomplete. Records from the histories of 238 TASO patients and
six Kitovu mobile patients were missing essential data. These patient histories were excluded from
analysis. In the case of Uganda Cares, the majority of service records were incomplete. Therefore, data
collectors sampled a small portion of Uganda Cares’ entire management information system (MIS)
database to construct complete patient histories.
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2. We found considerable variability in the quantity of drugs dispensed during patient visits. In some
cases, dispensing information was not recorded. As it was not possible to accurately assess patient drug
coverage between visits, we excluded any patient records that were missing dispensing information. In
other instances, records of drugs dispensed were several times higher than expected; in many cases this
also appeared related to data quality issues. Researchers manually examined the records of 108 patients
with high rates of ARV over prescription to correct miscoded visit dates or exclude duplicated visit
records.
3. Insufficient Uganda Cares MIS data were available to compare outcomes between UC-S and UCMOH. Kitovu Mobile employs only task-shifted services, thus no internal comparison is possible.
4. TASO site-shifted services are intended to specifically address patient geographic preferences. Therefore
exposure to task-shifting in TASO sites includes a large number of unmeasured variables. For instance,
did patients who never attended CDDPs simply live closer to the central site? A study comparing
various geographical locations of task-shifted studies would be useful in examining how site-shifting
improves patient access.
Finally, it is difficult to draw definitive conclusions about the effects of task- and site- shifted services
on client retention. Only stable TASO patients are eligible to acquire mobile services at the CDDP,
which—by their very nature—are often more easily accessible to clients than brick-and-mortar facilities.
Considering the preferential selection for stable clients, and self-selection by clients based on ease of
access, it is not surprising that retention is better for clients who attend CDDPs. Thus, it difficult to tease
apart those who remain in care longer because they can get services at CDDPs compared to those who
have been shifted to the CDDP simply because they have remained in care.
In our multivariate analyses, we focused on a subset of stable, long-term ART clients in order to
compensate for high rates of attrition during the early stages of care and to account for differences in
treatment-seeking behaviors. The positive results demonstrated in this analysis suggest that site- and
task-shifted services may indeed improve client retention and that further investigation of TASO’s CDDP
model is warranted.

LIMITATIONS OF COSTING DATA

Aside from the design limitations that prevent us from making any direct comparison of cost per visit
between task-shifted and non-task-shifted models, the data were collected retrospectively and thus
subjected to accounting errors and various data quality issues. These are common limitations of routine
program data, especially data from local and grassroots organizations. However, we only used data from
facilities that appeared to be comprehensive and we were able to impute some missing values by averaging
values from the facilities with complete data.
For TASO and UC where the structure is more complicated, with staff from central level providing
technical support to lower level facilities, the attribution of staff time to the various levels was based on
gross estimates made by supervisors and not on timesheets. Further, health workers providing services to
both ART and non-ART patients and their time spent on each type of patient, could be different, while
we assumed that time spent on non-ART patients was the same as for ART patients. Also, although
economic analysis would have been important to complement financial data, we were not able to collect
information on the economic costs including time and money spent on waiting and transportation as well
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as other types of out-of-pocket payments.
Comparison of costs between the three ASOs should be done with caution for several reasons. The level of
data completeness and data quality might be different across the three organizations. Nevertheless, these
costing data are important for these three organizations and other AIDS organizations in Uganda as well
as similar contexts for planning and budgeting. In addition, the study has demonstrated the feasibility of
using existing data to estimate cost per ART patient visit while highlighting the need to strengthen local
organization on collecting and using M&E data.
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DISCUSSION
We studied three ASOs that differed in size and service delivery approaches. Kitovu Mobile is a small
ASO providing ART in one region of Uganda using an outreach approach, thus its name—Kitovu
Mobile. UC is a large ASO which is part of an international organization, AHF, that is providing ART in
at least 11 African countries. In one UC model the clinics are entirely owned and managed by the ASO,
while in the second model, UC provides drugs and supervision to existing MOH clinics that offer ART
using MOH personnel and premises. TASO is another large ASO but it is indigenous to Uganda and
provides ART using clinics that are entirely managed by the ASO. These three ASOs, with their varying
approaches to task-shifting, provided us with a rich opportunity to explore a wide range of aspects of ART
task-shifting. The study focused on the following key aspects that are vital for informing the formulation
of guidelines and policies: what tasks are delegated, which cadre is involved in task-shifting, at what
locations task-shifting is taking place, and what the implications of task-shifting are in terms of quality
and outcomes of ART care.
This study shows that in the three ASOs almost all key tasks in ART, including determining eligibility,
initiating ART, and dispensing ARVs, can be feasibly shifted to lower level cadres or lower level facilities.
The study also shows a pattern of task-shifting where higher level HWs like physicians and clinical officers
are mainly delegating out tasks; the lowest cadres—the CHWs—are mainly being delegated tasks to;
and the middle cadre, the nurses and counselor, are delegating out almost as much as they are being
delegated to. Our data also show that task-shifting is taking place at both the centralized clinics and the
decentralized clinics. These patterns of delegation have been documented in the literature (Callaghan,
Ford, and Schneider 2010). However, our study helps highlight the fact that task-shifting is a continuum,
implying that tasks are not being heaped onto one cadre, namely the nurses. While nurses are gaining the
roles of determining eligibility and of initiating ART, they are also often delegating the traditional roles of
triage and taking vital signs for patients.
In the 2008 WHO guidelines task-shifting (TS) is characterized in one dimension—the personnel
involved in the task-shifting (WHO 2008). TS-I is where physicians delegate tasks to clinical officers and
nurses; in TS-II clinical officers delegate tasks to nurses; in TS-III nurses delegate tasks to CHWs; and in
TS-IV CHWs delegate tasks to expert patients. The data from our study adds two additional dimensions
thus enriching the above definition—type of tasks delegated and type of venue to which ART services
are delegated. These additional dimensions enable a further understanding of the nature and type of
task-shifting. For example, we found that while in the UC-S model the pharmacy workers delegate ARV
dispensing to the “HIV medic” (a CHW), in the TASO centralized model the pharmacy workers do not
delegate ARV dispensing.
WHO recommends that countries should determine competencies for cadres to whom tasks are shifted
and ensure that they receive requisite training to effectively perform these tasks (WHO 2008). In
our study we observed gaps in the training of health workers. While the majority of cadres providing
ART reported being trained in ART care, the proportion reporting training in specific competencies
relevant to the tasks they were performing differed widely. Among professional health workers—doctors,
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clinical officers, and nurses—a low proportion of 30 percent to 50 percent reported training in the key
competencies required of them: ART prescribing and dispensing. However, among the lay HWs—
HIV medics and expert clients—a higher proportion of 40 percent to 90 percent reported training in
ART counseling and health education, which are the key competencies required of them. The findings
are consistent with those of a survey of 44 health facilities across Uganda which found that among
professional HWs who prescribed ARVs, 76 percent of doctors, 62 percent of clinical officers, and 62
percent of nurses were trained in initiating patients on ARVs (Lutalo et al. 2009).
Quality of ART care is one of the potential concerns about delegating tasks to lower level HWs. A
number of studies have assessed the quality of ART care delivered by lower level health workers or CHW
and have concluded that shifting ART tasks to these cadres did not negatively impact quality of care
(Callaghan, Ford, and Schneider 2010). In our study we show that quality of care did not differ between
HIV medics and other health workers (doctors, clinical officer, and nurses) working at the same type of
clinic (UC). However, we observed a variation in quality by type of site—there was lower quality of care
in the community-based settings (TASO-CDDP) compared with the facility-based clinics (TASO-C).
However, it may not be accurate to make this comparison because the purpose of the client-provider
interaction at the community site differs from that at the central health facility. At TASO-CDDP the
purpose is to do a quick assessment and provide ARV refills for patients who are otherwise stable on
ARVs. At TASO-C the purpose of the client-provider interaction is a thorough clinical review, either for
clients who are in the initial phase of ART or those who have been referred from TASO-CDDP because
of side effects or poor response to ARVs.
Quality of care can also be affected by work overload resulting in congestion, long waiting periods, and
limited contact time with providers. Shifting some tasks to lower cadres is supposed to reduce the burden
on higher level HWs thus enabling more patient contact time. For example Chung et al. 2008 reported
that nurse-initiated ART reduces physician HIV-related workload by 78 percent. At the Reach Out
Mbuya ART clinic in Uganda it was reported that after a task-shifting intervention, the overall median
time spent at the clinic reduced from 206 to 83 minutes (Alamo et al. 2013). Our study has shown that
the overall median time spent at the UC-S model was 48 minutes while the waiting time was 33 minutes,
resulting in the patients spending 37.5 percent of the time at the clinic in contact with a provider.
However, the other models in our study were less efficient in using the patient’s time at the clinic in that
the proportion of time spent in contact with a provider ranged from 6.7 percent to 15.6 percent. These
findings suggest that some models of task-shifting can reduce waiting time and increase provider contact
time for ART.
A key question is whether task-shifting affects patient outcomes. On-time attendance of scheduled
drug-refill visits is associated with improved virologic treatment outcomes (El Khatib et al. 2011), thus
eliminating treatment gaps presents a critical challenge for ART providers. However, in our study the data
did not have reliable next scheduled medication pickup dates. Hence we used date-count projections for
the next pick-up based on documented patient regimen and number of pills distributed at last visit. We
selected 45 days’ lateness as our cutoff point for loss to follow-up. This timeline falls within the definition
as per a 2007 meta-analysis (Rosen, Fox, and Gill 2007) in which, “retention” referred to patients
known to be alive and receiving highly active ART at the end of a follow up period. For non-retention,
the studies in that review used cut-off points from 1 to 6 months late for a scheduled consultation or
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medication pick-up. In that meta-analysis 60 percent of patients were retained after 24 months. In our
study 75.3 percent of the patients were retained in care at 24 months.
Only TASO provided data from ART services delivered to patients at a central facility, and through a
community-based care model: the TASO-CDDPs. Bivariate analysis showed that retention at 12 and 18
months was significantly higher among those patients who attended any CDDP-based visits compared to
those who did not. However, as discussed before given the pre-selection of CDDP patients and the ease of
CDDP pick-up compared to visiting the central clinic, it is not surprising that the retention rate is better
for those who attend CDDPs.
Consistent with previous costing analyses (Mdege et al. 2013; Menzies et al. 2011; McCoy et al. 2011;
Bikilla et al. 2009; Martinson et al. 2009; Rosen, Long, and Sanne. 2008; Tagar et al. 2014), we found
that ART drug-related expenses accounted for a significant portion of the total ART-related cost, followed
by personnel and administrative costs. In particular, ART drugs accounted for nearly 50 percent of the
total expenses for Kitovu Mobile and TASO models, while this proportion was nearly 70 percent for
the UC model. Overall, the average annual cost per ART client among the three organizations ($331)
was lower than previous similar analyses conducted among 5 PEPFAR countries (Botswana, Ethiopia,
Nigeria, Uganda, and Vietnam; 2009 data), in which the median annual ART cost was $800 (Menzies et
al. 2011). The cost of ARV drugs has been reduced since then (Menzies et al. 2011; Harling and Wood
2007) which is likely the largest contributing factor for the lower annual ART cost in our study. In
addition, these organizations have matured and become more efficient in serving increased numbers of
ART clients (Harling and Wood 2007; Menzies, Berruti, and Blandford 2012). Lower ART costs suggest
that future ART programs may become even less expensive, especially with the continuing reduction of
drug costs.
The distribution of costs was quite comparable between Kitovu Mobile and TASO, which is consistent
with previous study findings (Mdege et al. 2013; Menzies et al. 2011; Martinson et al. 2009; Tagar et al.
2014; Harling and Wood 2007; Larson et al. 2013). Kitovu Mobile employed a large number of expert
clients (177) for their outreach activities, resulting in personnel costs comparable to that of TASO and
higher than the UC’s personnel costs. However, the interpretation of this finding should be cautious
because UC employed a number of staff from the government and their salary data was not fully captured
in this costing data. In addition, UC also used the facilities offered by the government free of charge,
resulting in a much lower operational cost compared to Kitovu Mobile and TASO. The lack of personnel
and operational costs within UC is likely the main reason contributing to the overall lower ART cost per
client for UC model. This ultimately affects the cost distribution within the UC model. Further, even
though ART expenses for UC accounted for nearly 70% of the total cost, the total UC ART cost in terms
of absolute dollar value was quite comparable with Kitovu Mobile and TASO (data not shown).
In summary, the studies reviewed tend towards a general conclusion that task-shifting in any of the
three dimensions—by type of provider, by level of facility, and by complexity of task delegated—mostly
seems to result in the same level of outcomes when compared to the minimally task-shifted ideal of a
doctor providing ART initiation and maintenance in a hospital. However, some studies suggest better
results from task-shifted ART care while some others suggest poorer results from task-shifted ART care.
Our study, which reviewed types and nature of task-shifting and examined the outcomes in three major
ASOs in Uganda, has shown similar conclusions. When we compared task-shifting by level of facility we
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found that community-based settings were similar to facility-based clinics with regard to the following
indicators: ARV knowledge of clients: provider performance in clinical assessment of patients, adherence
counseling, and counseling about side effects. Our data also showed that community-based settings had
better retention in ART than facility-based clinics. However, while overall client satisfaction was quite
high in both types pf clinics, community-based settings performed less well than facility-based settings in
providers addressing clients’ complaints and in time efficiency.
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CONCLUSIONS
This study shows that in the three ASOs almost all key tasks in ART including determining eligibility,
initiating ART, and dispensing ARVs can be feasibly shifted to lower level cadres or lower level facilities.
While the WHO has defined task-shifting using one dimension—the personnel involved in the taskshifting—the data from our study add two additional dimensions that could be used for a more
descriptive definition—type of tasks delegated and type of venue to which ART services are delegated.
Our study has also identified training gaps in specific areas of competence among professional and lay
HWs currently providing ART in task-shifted services.
Our study has shown a number of variations in the process and outcomes of service delivery depending
on how the task-shifted models were designed. Some of the models studied demonstrated efficient use
of patient time while others did not. Our findings also suggest that the entirely outreach-based or more
task-shifted model of Kitovu Mobile costs less per visit compared to the less task-shifted model of TASO.
However, the distribution of costs between key cost elements such as personnel, drugs, lab tests, and
operations differs between Kitovu Mobile and TASO and could partly explain the difference in cost
per visit. The UC cost per visit is closer to Kitovu Mobile. It should, however, be noted that due to the
challenges of compiling operational/office costs, the cost per visit at UC was likely an underestimate.
While our study has demonstrated that the quality of services was lower at the community-based clinics
than at the health facility-based clinics our findings suggest that by employing a task-shifted, communitybased ART service model, TASO has expanded patient access to ARV refill resulting in high retention
rates.
The findings from our study appear to agree with the available literature that task-shifting was associated
with increased access and retention and reduced cost of ART care. Our data also showed that, in one
ASO—Uganda Cares, where we were able to compare provider performance—there was no difference in
the performance of key ART tasks between LHWs to PHWs. Findings from this study provide important
insight on costs and outcomes associated with task-shifting in facility-based versus outreach/communitybased service environments.
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RECOMMENDATIONS
yy Consideration should be made to expand the description of task-shifted services along more than one
dimension: the type of cadre, the type of facility and the type of task.
yy When rolling out task-shifting in Uganda it will be important to conduct a training needs assessment
of both the professional and LHWs and provide them with the required training in order to ensure
competence and quality of care in task-shifted services. Given the likelihood of staff attrition,
recruitment of new staff, and changes in guidelines, special attention should be paid to continued
medical education for all cadres of staff involved in ART care.
yy In our study we have shown that quality of care did not differ between HIV medics and other health
workers (doctors, clinical officer, and nurses) working at the same type of clinic (UC). This suggests
that the HIV medics are a cadre worth exploring for the scale-up of task-shifting.
yy The reasons for the efficient use of patient time in models such as UC-S should be further explored and
shared widely as promising practices that can strengthen other task-shifting models.
yy Our data showed that community-based settings had better retention in ART than facility-based
clinics. Given their low levels of drug coverage, yet high levels of retention, Kitovu Mobile should
consider examining client viral loads to proactively identify any systemic concerns regarding viral
suppression and drug resistance.
yy Kitovu Mobile should examine current ART dispensing (or documentation) practices as, on average,
the documentation shows that clients are receiving insufficient drugs to cover the interval between
refills, and only 18.5 percent of clients achieved 95 percent drug coverage during their time in care.
yy Future programs might benefit from examining the distribution of costs among the different elements
of a task-shifted program in order to identify care packages that deliver the highest quality of care at the
lowest cost.
yy The collection of costing data to measure unit costs, cost-effectiveness, and cost-efficiency remains
critical. ART service delivery sites in country would benefit from implementing a standardized cost
data-capture tool or M&E system that allows for comparison across sites.
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